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Abstract 
Background: Despite a shared link to cognitive processing of health information 
suggested by their definitions, information on the association between uncertainty and  
health literacy is scarce.  Their relationship has not been studied in pancreatic cancer 
patients.   
Aims: To evaluate uncertainty and health literacy in pancreatic cancer patients, examine 
their bivariate correlation, and determine significant predictors.   
Methods: This descriptive, cross-sectional study was conducted in a comprehensive 
cancer center.  Uncertainty was measured using the Mishel Uncertainty in Illness Scale -
Community and health literacy was measured using the Cancer Health Literacy Test 30.   
Spearman’s rho tested correlation and linear regression models were used to test for 
predictors.  Bias corrected, accelerated bootstrap was used when regression residuals 
violated normality.   
Results: The sample (N=82) was predominantly male (55%), White/Caucasian (79%), 
married 74%), and receiving neo-adjuvant treatment in anticipation of potential surgical 
resection (49%).  Mean age was 64.59 years ranging from 30 to 80.  A significant but 
weak correlation was noted between uncertainty and health literacy (rs = -.24, p = .032).  
Health literacy was not a significant predictor of uncertainty after adjusting for age, 
gender, education, race/ethnicity, and phase of care.  Education was a significant 
predictor of uncertainty (p = .001; ηp 2 = .217) and health literacy (p =.003; ηp 2 = .174).  
Phase of care was a significant predictor of uncertainty (p = .001; ηp 2 = .221). 
 
 
vi 
 
Conclusion: Health literacy and uncertainty had a significant albeit weak correlation. 
Health literacy is multifaceted and some of its features were accounted for by other 
socioeconomic and clinical variables.  Education was a significant predictor of 
uncertainty and health literacy. Significant differences in the ability to interpret health 
events were found through the different phases of the pancreatic cancer experience.  
Sample homogeneity restricted inferences and generalizability on effects of 
race/ethnicity.  
Keywords: uncertainty, health literacy, pancreatic cancer  
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Summary of the Study  
The research protocol “Uncertainty in Illness and Uncertainty in Pancreatic 
Cancer Patients” was executed following approval from the Institutional Review Board 
(IRB) of The University of Texas MD Anderson Cancer Center on May 10, 2017 and 
from the Committee for the Protection of Human Subjects (CPHS) of The University of 
Texas Health Science Center at Houston on June 5, 2017.   The aims of this descriptive, 
cross-sectional research study were to: 
1. Describe uncertainty using the Mishel Uncertainty in Illness Scale – Community 
instrument (MUIS-C) and health literacy using the Cancer Health Literacy Test – 
30 (CHLT-30) in the pancreatic cancer population  
2. Examine the association between uncertainty and health literacy in the pancreatic 
cancer patient population  
3. Examine if health literacy is a significant predictor of uncertainty after adjusting for 
age, gender, race and ethnicity, education level, and disease treatment stage 
Data collection began on June 9, 2017 and concluded on December 22, 2017.  
Study instruments were administered to participants with pancreatic adenocarcinoma 
recruited in the outpatient clinics at MD Anderson Cancer Center.  Following application 
of inclusion, exclusion, and sample selection criteria 91 participants were registered and 
the final sample comprised of 82 evaluable pancreatic cancer patients. 
Two study protocol amendments were submitted and approved by the Institutional 
Review Board.  The first approved amendment clarified that patients with pancreatic 
adenocarcinoma who have either received oncologic treatment for another primary 
malignancy or have active disease from another primary malignancy within the past 5 
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years were ineligible for the study unless the other primary malignancy was a non-
melanoma skin cancer.  The second approved amendment clarified that participants 
complete the MUIS-C before their meeting with the physician.  Study procedure already 
adhered to this but it was specified with a formal amendment. 
 Descriptive statistics were employed to describe uncertainty and health literacy.  
Spearman’s rho tested correlation and linear regression models tested for significant 
predictors.  Bias corrected, accelerated bootstrap was utilized when regression residuals 
violated normality.  The findings revealed a significant albeit weak correlation between 
uncertainty and health literacy.  Education level was a significant predictor of uncertainty 
and health literacy. Significant differences in uncertainty levels were found through the 
different phases of the pancreatic cancer experience.  Sample homogeneity restricted 
inferences and generalizability on effects of race/ethnicity.  
 A manuscript was written describing the background and significance of the 
research questions along with methods, results, and implications for future research.  
Appendices A-I contain supplemental information from the study including the IRB and 
CPHS approval documents, MDACC protocol and IRB-approved amendments, study 
consent form, study instruments, and human subjects research training certificates.   
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Specific Aims 
Uncertainty during the cancer illness experience is associated with poor health 
outcomes (Lin et al., 2015).  Although uncertainty has been studied in patients with 
breast cancer, prostate cancer, brain tumors, renal malignancies, gynecologic 
malignancies, and lymphoma (Bailey et al., 2011; Cahill et al., 2014; Elphee, 2008; 
Germino et al., 2013; McCorkle et al., 2009; Mishel et al., 2002; Mishel et al., 2009; 
Parker et al., 2013), it has not been explored with a focus on pancreatic cancer patients.  
Many of these studies show that uncertainty interventions aimed at enhancing knowledge 
about diagnosis, management and surveillance as well as communication skills are 
effective.  However, assessment of uncertainty in the pancreatic cancer population is 
necessary prior to effective implementation of interventions.    
Pancreatic cancer has unique characteristics that warrant baseline studies prior to 
implementing interventions found effective in other populations. The pancreatic cancer 
experience is fraught with ambiguity, complexity, and unpredictability due to an 
aggressive and recalcitrant biology, lack of prevention guidelines and screening standards 
for the general population, and lack of expert conformity on the sequence of treatment for 
patients with resectable disease (Halperin & Varadhachary, 2014; Reynolds & Folloder, 
2014).  These attributes of pancreatic cancer predispose patients to an illness experience 
beset with uncertainty.  
Uncertainty is defined as the inability to determine the meaning of illness-related 
events and it is conceptualized as having associated antecedents and consequences 
(Mishel, 1988).  Antecedents and predisposing factors that can potentially influence 
uncertainty are important to explore. One factor to examine is health literacy, defined as 
5 
 
 
 
the capacity to obtain, process, and understand basic health information and services 
needed to make appropriate health decisions (Dumenci et al., 2014).  Health literacy has 
emerged essential in health promotion studies and has been found influential in cancer 
health outcomes (Altsitsiadis et al., 2012; Busch, Martin, DeWalt, & Sandler, 2015; 
Halverson et al., 2015; Husson, Mols, Fransen, van de Poll-Franse, & Ezendam, 2015).  
However, it has not been studied with a focus on pancreatic cancer patients. In fact, the 
association between health literacy and uncertainty has yet to be explored in the cancer 
population and there is a dearth of general information on the association between these 
variables despite a shared connection to cognitive processing of health information 
described in their respective definitions. Evaluating this association is valuable to 
understanding the relevance and applicability of both in improving the care of pancreatic 
cancer patients.  The aims of the study are:   
1. Describe uncertainty in the pancreatic cancer patient population using the Mishel 
Uncertainty in Illness Scale – Community instrument (MUIS-C) 
2. Describe health literacy using the Cancer Health Literacy Test – 30 (CHLT-30) and its 
association to uncertainty in the pancreatic cancer patient population  
 Hypothesis 2a: Higher levels of health literacy are significantly correlated with lower 
levels of uncertainty in pancreatic cancer patients 
 Hypothesis 2b: Health literacy is an independent predictor of uncertainty in pancreatic 
cancer patients 
3. Examine if age, gender, race/ethnicity, education status, and phase of care are 
significant predictors of uncertainty and health literacy in the pancreatic cancer 
population 
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 Hypothesis 3a: Education status, race/ethnicity, and phase of care are significant 
predictors of uncertainty and of health literacy in pancreatic cancer patients 
 Hypothesis 3b: Age and gender are not significant predictors of uncertainty or of 
health literacy in pancreatic cancer patients 
 Pancreatic cancer has distinct characteristics that predispose patients to 
uncertainty.  Successful understanding and navigation of the complexities of disease and 
treatment that can mitigate uncertainty require proficient health literacy. Given the 
cognitive processing of health information described in their respective definitions, 
exploring the association between uncertainty and health literacy has merit and beneficial 
implications for clinical practice and research. This study will explore uncertainty and 
health literacy as distinct phenomena in the pancreatic cancer population and examine the 
relationship between the two variables. This study will fill significant research gaps with 
information that can improve clinical interventions, research and patient outcomes.  
Background and Significance 
Pancreatic cancer is the fourth leading cause of cancer deaths in the United States 
(American Cancer Society [ACS], 2016).  It has no established screening or prevention 
guidelines, no hallmark symptoms to help distinguish disease at an early stage and 80% 
of pancreatic cancer patients present with metastatic and locally advanced disease at 
initial diagnosis (Chatterjee et al., 2012).  This leaves a minority of patients eligible for 
curative treatment.  For patients undergoing treatment, there is debate among experts 
regarding the sequence of therapy for patients with resectable disease (Brana Reynolds & 
Folloder, 2014; Evans et al., 2008; Varadhachary et al., 2008).  The National 
Comprehensive Cancer Network (NCCI) recommends upfront surgery for potentially-
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resectable disease but expert consensus and a number of phase II clinical trials support 
administration of neoadjuvant chemotherapy in selected patients with biopsy-proven 
carcinoma prior to surgery (Halperin & Varadhachary, 2014).  Even for patients who 
complete treatment, the widely-acknowledged high recurrence rate undermines 
confidence in having achieved long-term survival or cure. The 5-year survival rate for 
pancreatic cancer remains low at 6% (ACS, 2016) and approximately 80% of patients 
undergoing resection with curative intent develop distant metastasis or local recurrence 
within five years of surgery (Halperin & Varadhachary, 2014).  With a grim prognosis, 
patients may become overly vigilant and mistakenly interpret symptoms unrelated to 
malignancy as indications of disease recurrence. These factors contribute to uncertainty 
throughout the patient’s illness experience from initial presentation to survivorship and 
end-of life.   
Uncertainty in Illness (Figure 1), is the inability to determine meaning of illness-
related events (Mishel, 1988). It is a cognitive state that occurs when lack of adequate 
knowledge leads to the inability to frame or categorize an event.  Studies on uncertainty 
in multiple cancer populations have utilized Mishel’s theoretical framework and have 
suggested that uncertainty influences psychosocial adaptation and can affect disease 
outcomes (Lin et al., 2015).  Patients with cancer have also been found to benefit from 
interventions aimed at addressing uncertainty during their illness (Mishel et al., 2009). 
Studies on uncertainty have been conducted on patients with breast cancer (Germino et 
al., 2013; Gil et al., 2006), prostate cancer (D. E. Bailey, Jr. et al., 2011; D. E. Bailey, 
Mishel, Belyea, Stewart, & Mohler, 2004; Kazer, Psutka, Latini, & Bailey, 2013; Mishel 
et al., 2002; Mishel et al., 2009; Wallace, 2005), gynecological malignancies (McCorkle 
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et al., 2009), renal malignancies (Parker et al., 2013), lymphoma (Elphee, 2008), and 
brain cancer (Cahill, Gilbert, & Armstrong, 2014; Cahill, Lin, et al., 2014; Lin et al., 
2015). However, there is a research gap in examining uncertainty in the pancreatic cancer 
experience and this gap requires research aimed at discovering baseline information so 
that the uncertainty experienced by pancreatic cancer patients is evaluated before testing 
and implementing interventions that have been found effective in other cancer 
populations.  
Although uncertainty has been explored in patients with other aggressive 
malignancies, there are unique aspects to pancreatic cancer that warrant investigation 
focused on this population. The lack of conformity of treatment sequence for curable 
disease can cause confusion among newly diagnosed patients seeking information and 
guidance in making treatment decisions. Conflicting information from clinicians on 
whether one should pursue upfront surgery versus neo-adjuvant therapy can present 
complex challenges that potentiate uncertainty and require a high level of health literacy 
to parse through. There are other distinct aspects in the pancreatic cancer population such 
as its widely-acknowledged high recurrence rate. A recent study that examined fear of 
recurrence in 240 patients with pancreatic and peri-ampullary tumors included 94 patients 
with pancreatic adenocarcinoma who had completed treatment with curative intent and 
found that 37% of these patients reported frequent fearful thoughts, emotional 
disturbance and functional impairment (Petzel et al., 2012).  This concern over the 
unpredictability of disease merits investigation.  In a disease with vague but distressing 
symptoms, aggressive and recalcitrant biology, and complex treatments, it is necessary to 
assess precursors and associated factors to identify ways to mitigate uncertainty.  
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Uncertainty is conceptualized by Mishel’s Uncertainty in Illness Theory (Figure1) 
as having antecedents namely the stimuli frame, the patient’s cognitive capacity, and 
structure providers that include patient education, social support, and credible authority 
(Mishel, 1988). Stimuli frame is the composition and structure of the stimuli in illness 
and treatment-related events and include event unfamiliarity, a lack of symptom pattern, 
and lack of event congruence (Mishel & Braden, 1988).  Structure providers are 
information and support sources that help patients interpret variables in the stimuli frame.  
Structure providers include credible authorities, education, and social support (Mishel, 
1988).  Cognitive capacity refers to the information-processing abilities that enable 
patients to make sense of their experience (Mishel et al., 2009).  The theory posits that an 
inability to form a cognitive structure allowing for interpretation of illness-related events 
can lead to uncertainty.   
 
Figure 1. Uncertainty in Illness (Mishel, 1988) 
One factor not explicitly addressed in the theoretical framework is health literacy, 
defined by the Institute of Medicine and by the US Department of Health and Human 
Services as the degree to which individuals have the capacity to obtain, process, and 
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understand basic health information and services needed to make appropriate health 
decisions (Cutilli & Bennett, 2009; Dumenci et al., 2014).  Concept analyses have 
ascribed reading and numeracy skills, comprehension, capacity to use information in 
health care decision-making, and successful functioning as a health care consumer as 
defining attributes of health literacy (Mancuso, 2008; Speros, 2005).  Mancuso (2008) 
classifies the attributes in three categories with the first being capacity which involves the 
verbal, numerical, and social skills essential to advocating for oneself while negotiating 
the health care system.  The second is comprehension which involves the interaction of 
logic, language, and experience essential to interpretation of information.  The third is 
communication which involves intake, processing, output, and feedback of messages 
through speech, writing, or behavior.  In addition to having these attributes, health 
literacy has been described as having three classes (Nutbeam, 2000).  Functional literacy 
involves reading and writing skills for everyday situations while interactive literacy 
involves advanced cognitive skills combined with social skills that allows a person to 
extract information, derive meaning from different forms of communication and apply 
such to changing circumstances (Nutbeam, 2000).  Critical literacy involves cognitive 
skills combined with social skills applied to critically analyze information and utilize 
such to exert greater control over life events (Nutbeam, 2000; Chinn, 2011).    
The definition and conceptualization of health literacy suggest a link to 
uncertainty but thee variables have not been studied in association with each other in 
cancer patients.  In fact, there is a dearth of information on the relationship between these 
variables in general. Literature search with the terms “uncertainty” and “health literacy” 
using the Cumulative Index of Nursing and Allied Health Literature (CINAHL) 
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generated only one report out of 12 results that actually studied the association between 
the two variables and it was not in the cancer population. The report is an abstract by 
Mock (2013) describing a pilot study to examine the correlation between health literacy 
and uncertainty during acute hospitalization in 25 older adults with heart failure. The 
abstract reported health literacy to be significantly correlated to uncertainty (Mock, 
2013). A search using Pubmed generated no research reports examining the association 
between these variables. One article discussed health literacy in advance care planning in 
the context of proposing a theoretical model on Uncertainty in advance care planning for 
African Americans (Melhadho and Bushy, 2011).  The theory posits that improving 
health literacy skills and addressing domains of the uncertainty in advance care planning 
can promote end-of life discussions decision-making (Melhadho and Bushy, 2011). The 
absence of prior research on the uncertainty of pancreatic cancer patients, the scarcity of 
information on the relationship of uncertainty and health literacy, and the lack of 
information on health literacy in the pancreatic cancer population underscores the 
significance of this study.  
Health literacy has evolved into an essential component in efforts to improve 
health outcomes and is included in Healthy People 2020 as an objective in the promotion 
of health communication (Office of Disease Prevention and Health Promotion; 2016).  
According to the US Department of Education, only 12% of English-speaking adults 
have proficient health literacy skills (Hepburn, 2012, US Department of Health and 
Human Services, 2010).  If this pattern holds true in the pancreatic cancer population, this 
is a detriment to care access and delivery as patients in this population are often required 
to navigate their way through information systems and interact with health care providers 
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in order to understand their illness,  access appropriate services and participate effectively 
in health care decision making.   
Health literacy has become more critical as patients try to navigate the ever-
evolving health care environment and traverse information pathways. The promulgation 
of web-based medical information, shifts in health policy and system access, as well as 
advances in cancer management make health literacy essential to successful navigation of 
the health care system. Exploring health literacy is especially significant in populations 
such as pancreatic cancer patients where treatment decisions can be complex.       
There is a growing body of evidence suggesting that limited health literacy negatively 
affects cancer prevention and disease management behaviors. Studies in patients with 
colon cancer (Pendlimari, Holubar, Hassinger, & Cima, 2012), breast cancer (Buki, Yee, 
Weiterschan, & Lehardy, 2015; Halbach et al., 2015; Kamimura et al., 2016), cervical 
cancer (Sentell, Braun, Davis, & Davis, 2015), prostate cancer (Kayser, Hansen-Nord, 
Osborne, Tjonneland, & Hansen, 2015), lung cancer (Milne et al., 2015), and head and 
neck cancer (Koay et al., 2013) have explored different aspects of health literacy and the 
impact of poor literacy on health outcomes in these patient populations.  Preparation 
work for this proposal includes a search of Medline, Pubmed, CINAHL, and PsychINFO 
to review the body of research on health literacy and cancer health outcomes. Fifteen 
studies were found involving 11,326 patients with various cancers including melanoma, 
colorectal cancer, prostate cancer, breast cancer, and lung cancer. The health outcomes 
studied were quality of life (Husson, 2015; Song, 2012; Halverson, 2015; Milne, 2015), 
distress (Koay, 2013), decision satisfaction and regret over decision outcomes (Hawley, 
2008), mental well-being (Song, 2012), medication adherence (Rust, 2011; Rust, 2012), 
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sunscreen and sunbed use (Altsitsiadis, 2012), receipt of treatment including 
chemotherapy, reconstructive surgery, salvage hormone therapy, genetic counseling 
(Mahal, 2015; Busch, 2015: Winton, 2016), disease status at diagnosis (Wolf, 2006), and 
survivorship (Hulett, 2015).  The results of the quantitative studies primarily support low 
health literacy as having a negative association with health outcomes and the results of 
the qualitative studies suggest that patients perceive low health literacy as a barrier to 
good outcomes. The research gap in evaluating health literacy in the pancreatic cancer 
population needs to be addressed. Because health literacy may be a critical and 
modifiable factor in improving care and reducing health disparities, it is important to 
explore this in pancreatic cancer patients as well. 
This planned study will be conducted within the context of a conceptual 
framework adapted from the Uncertainty in Illness Theory. The adaptation that will guide 
this planned study is depicted in Figure 2 and focuses on antecedents of uncertainty with 
incorporation of health literacy into the framework.   
  
Figure 2. Antecedents to Uncertainty in Illness. Adapted from Uncertainty in Illness (Mishel, 
1998) 
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The study will also examine demographic factors as potential determinants of uncertainty 
and health literacy to evaluate if there are demographic predictors that can guide future 
research and identification of individuals who are more susceptible to uncertainty.  Prior 
health literacy assessment in 1,306 cancer patients found no significant mean difference 
between men and women (p=.247) but the scores among African Americans were found 
to be significantly lower (p < .0001) than White participants (Dumenci et al., 2014).  This 
study found that participants with limited health literacy consisted of an 
overrepresentation of African-Americans, patients who were undereducated, and patients 
with lower income (Dumenci et al., 2014).  Meanwhile aggregate data on different 
population subgroups described in the Uncertainty in Illness Scales Manual indicate no 
difference in the mean scores based on gender or age but that scores decrease with an 
increase in level of education (Mishel, 1997).  These demographic variables will be 
evaluated as this can influence the design and implementation of future studies and 
intended population of intervention programs.   
Innovation 
Given the unique characteristics of pancreatic cancer, it is necessary to obtain baseline 
information before translating findings from other populations to patients with pancreatic 
cancer. This study will be innovative and significant to care delivery as it will explore 
important variables that have not been studied in this population. With the growing 
emphasis on health literacy, this study will explore health literacy as a structure provider 
antecedent to uncertainty within the context of the Uncertainty in Illness model.  The 
innovation extends beyond theory testing and concept development as its practical 
implications can significantly improve patient outcomes, nursing interventions, and guide 
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future research efforts. The paucity of information on uncertainty and health literacy 
specific to the pancreatic cancer population is a barrier to improving health literacy and 
mitigating uncertainty.  Results from this planned study can prove helpful in eventually 
allowing nurses and health care givers to influence the patient’s ability to understand 
illness events and process health information and services that enhance their engagement 
in health decisions towards better outcomes. 
Research Design and Methods  
The study is designed as an observational, cross-sectional study seeking to 
describe uncertainty in illness and health literacy in the pancreatic cancer population and 
explore the relationship between variables.  A cross-sectional design will be utilized to 
gather information during a single period of data collection with no repeat 
measures. Given the absence of prior studies on uncertainty and health literacy in 
pancreatic cancer patients, this design is appropriate as an initial exploration that can 
provide groundwork for future research.   
Population, Sample, Sampling Procedure 
The study population will be pancreatic cancer patients and the sample will be 
recruited from the pancreatic cancer clinics in the Gastrointestinal Center at The 
University of Texas MD Anderson Cancer Center. An estimated total of up to 91 patients 
will be invited to participate.  With an anticipated response rate of approximately 90%, an 
analyzable sample size of 82 will be produced. The primary objective is to collect the 
uncertainty and health literacy information in pancreatic cancer patients and assess the 
correlation between uncertainty and health literacy. The primary endpoints are  the 
Mishel uncertainty scores  which is defined as the summation of all the questions scores 
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and the cancer health literacy test scores which is defined as the number of questions that 
the patient answers correctly.  With 82 patients in total, given the two-sided type I error 
of 5%, we will have an 80% power to detect a Pearson’s correlation of 0.3 between 
uncertainty score and cancer health literacy score. nQuery/nTerim version 3.0 was used 
for the sample size justification. 
The pancreatic surgical clinic had over 1900 visits from patients who had ICD-10 
diagnosis codes corresponding to pancreatic cancer in the year 2015. This number 
comprises a combination of patients who are newly diagnosed, under active treatment, 
and survivors who attend clinic ongoing five days a week. It is expected that accrual will 
be accomplished over a 6 month period. Consecutive sampling will be employed and 
patients will be recruited in the order of their visit and appointment dates. 
Inclusion Criteria  
1. Patients with a diagnosis of biopsy-proven pancreatic adenocarcinoma who are 
newly-diagnosed, receiving active treatment, receiving active oncologic 
surveillance or treatment follow-up, or receiving survivorship care  
a. Newly diagnosed – a patient who has biopsy confirmation of pancreatic 
adenocarcinoma but has not started treatment 
b. Active treatment – a patient who is currently receiving cancer therapy 
(chemotherapy, surgery, radiation) or treatment for complication of 
pancreatic adenocarcinoma 
c. Oncologic surveillance – a patient who is receiving treatment-related 
follow-up (post-op care, chemotherapy or radiation follow-up) 
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d. Survivorship care – a patient who is 6 months or more from completion of 
treatment and has no evidence of recurrence or active disease  
2. Patients who meet the above criteria and are 18 years of age or older 
Exclusion Criteria   
1. Patients who have a history or current diagnosis of another primary malignancy 
other than pancreatic adenocarcinoma  
2. Patients unable to speak, read, or write in English will be excluded because the 
instruments are in English 
3. Pancreatic adenocarcinoma patients who are under 18 years of age 
Recruitment  
Patients who meet the eligibility criteria will be invited to participate in the study 
when they present for a clinic visit.  This will occur during a patient’s scheduled visit to 
the clinic. Patients will not be required to report to clinic for the purpose of study 
participation on days when they otherwise do not have a scheduled visit for cancer 
treatment or follow-up.  The voluntary nature of participation will be explained and 
informed consent will be obtained from patients who agree to take part in the study. The 
recruitment process will be as follows: 
1. Primary investigator will review consecutive patients’ medical records to 
determine eligibility 
2. Primary investigator will approach the patient, explain the study and invite them 
to participate 
3. The primary investigator will explain the Informed Consent process and voluntary 
nature of study participation  
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4. The primary investigator will address patient questions 
5. The principal investigator will obtain signatures for Informed Consent 
6. A copy of the completed consents will be kept in the electronic health record 
system  
Patient Registration 
Enrolled patients will be registered into the Clinical Oncology Research System 
(CORe) which serves as the MD Anderson Cancer Center institutional patient data 
management system. 
Instruments 
The Mishel Uncertainty in Illness Scale – Community Form (MUIS-C) will be 
used to measure uncertainty.  The MUIS-C has 23 items scored 1 to 5 on a Likert 
scale.  The item scores are summed with a higher cumulative score indicating greater 
uncertainty.  The MUIS-C has been used extensively with cancer patients.  The MUIS-C 
was adapted from the 33-item Mishel Uncertainty in Illness Scale (MUIS-A), originally 
developed to evaluate uncertainty in acutely ill, hospitalized adults (Bailey et al., 
2011).  Items from the MUIS-A specifically relating to inpatient hospitalization were 
removed and the remaining questions comprise the items for the MUIS-C version.  The 
MUIS-A was developed through expert analysis and validation of the MUIS-A was 
utilized to support the validity of the MUIS-C (Bailey et al., 2011).  In analyses of MUIS-
C scores from 18 samples of chronically ill adults (total n=1068), Cronbach’s alpha 
exceeded 0.85 in a large majority of the samples indicating the reliability of MUIS-C as 
comparable to the 0.87 reported for the MUIS-A (Bailey et al., 2011).   
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The Cancer Health Literacy Test – 30 (CHLT-30) (Dumenci, et. al., 2014) will be 
used to measure health literacy.  The 30-item CHLT-30 was created to assess literacy 
along the cancer health literacy continuum.  Its development was described in a 
publication of a study involving 1,306 adults with heterogenous cancer diagnoses, 
educational attainment, and health insurance and marital status.  Pancreatic cancer was 
not listed as a category among the 11 diagnostic cancer types represented by the 
participants in the study sample.  The reliability evidence for the CHLT-30 was a 
Cronbach’s alpha of 0.88, McDonald’s omega of 0.89, 2-week test–retest reliability of 
0.90, and 6-month test–retest reliability of 0.90.  There was support for the 
unidimensional scale and all variables had significant factor loadings of > 
0.44.  Structural equation modeling supported external validity with self-confidence in 
engaging in health decisions specified as a latent variable measured by two positively and 
two negatively worded items.  The test score is the total number of correct responses and 
ranges from 0 to 30.  The instrument response time ranges from 10-15 minutes (Dumenci, 
et. al., 2014). 
A Patient Demographic Form will be utilized to record demographic information 
including age, gender, education status, ethnicity, and marital status.  The time to 
complete all instruments should not exceed 20 minutes.    
Data Collection Procedures 
Enrolled patients will complete the instruments in the clinic. Collaboration and 
coordination with the clinic team seeing the patients will be established for the study prior 
to beginning screening, recruitment, and enrollment.  
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1. Data will be collected by paper and pencil surveys with the research staff entering 
information into the web-based REDCap application hosted by MD Anderson 
Cancer Center (https://redcap.mdanderson.org) 
2. A member of the research staff will be available during the time the patient is 
completing the instruments 
3. The research staff may not provide any answers to the specific questions on the 
questionnaire but can address questions about study participation or the process of 
form completion  
4. Only the patient may complete the form. Family members or patient companions 
to the visit may not answer or complete the forms. If there are deficits that makes 
reading the questionnaire or writing the responses difficult, the questionnaire can 
be read to the patient by the research staff or the patient companion and the 
responses recorded according to the patient response 
5. Research staff will review the forms to ensure completeness and will transport the 
completed forms to a secure location in the primary investigator’s office  
The time to complete the instruments should not exceed 20 minutes. The primary 
investigator or designated research staff will enter the data into a secure database. Data 
entry and instrument scoring will be conducted according to the instrument manuals and 
study protocol prepared for the study.   
Data Analysis  
Questionnaire scores will be calculated based on standardized manuals 
associated with each survey instrument.  Descriptive statistics will be used to 
summarize scores of the questionnaires according to respective scoring manuals for 
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each of the measures. The distribution of each continuous variable will be summarized 
by its mean, standard deviation, median, and range.  The distribution of each 
categorical variable will be summarized in terms of its frequencies and percentages.  
The difference in uncertainty and health literacy scores will be assessed between 
groups (e.g. gender, education levels) by a two-sample t-test or ANOVA if the data is 
normally distributed; otherwise a Wilcoxon rank sum or Kruskal-Wallis test will be 
used.  The association between uncertainty scores and health literacy score will be 
examined by Pearson correlation. To identify factors associated with uncertainty or 
health literacy scores of the survey measures, for example, the patient education status, 
age, ethnicity, and gender, multivariate linear regression will be performed to examine 
their effects.  
Specifically, the hypotheses testing and anticipated results are as follows:  
1. Describe uncertainty in the pancreatic cancer patient population using the MUIS - 
this primary, exploratory aim will assessed using descriptive analysis    
2. Describe health literacy using the CHLT-30 and its association to uncertainty in the 
pancreatic cancer patient population  
Hypothesis 2a: Higher levels of health literacy are significantly correlated with 
lower levels of uncertainty in pancreatic cancer patients - Pearson product 
moment correlation coefficient will be calculated. Kendall’s tau b or Spearman rho 
will be used if there is not a linear relationship or normal distribution. The 
anticipated result will be an inverse linear association between uncertainty and 
health literacy.  
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Hypothesis 2b: Health literacy is an independent significant predictor of 
uncertainty in pancreatic cancer patients - Health literacy will be included in 
multivariate regression to evaluate if it is a significant predictor of uncertainty. 
3. Examine significant demographic predictors of uncertainty and health literacy in the 
pancreatic cancer population 
Hypothesis 3a: Education status and ethnicity are significant predictors of 
uncertainty and of health literacy in pancreatic cancer patients – Multiple linear 
regression will be performed to determine if education status and ethnicity are 
significant predictors for uncertainty and multivariate regression will be also be 
performed assess if they are significant predictors for health literacy as well. The 
anticipated results will be that education status and ethnicity will be significant 
predictors for both health literacy and uncertainty. 
Hypothesis 3b: Age and gender are not significant predictors of uncertainty or of 
health literacy in pancreatic cancer patients - Multivariate regression will be 
performed to determine if education status and ethnicity are significant predictors for 
uncertainty and multivariate regression will be also be performed assess if they are 
significant predictors for health literacy as well. The anticipated results will be that 
neither age not gender will come out as significant predictors for either uncertainty 
or health literacy.   
Study Limitations  
The lack of prior studies on uncertainty and health literacy focused on the 
pancreatic cancer population is a constraint as there is limited information to guide this 
investigation in this population. Sampling bias will be a concern as this sample will be 
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recruited from patients who have the ability to navigate the referral system and travel 
then to access care at a high-volume comprehensive cancer center.  The participants will 
thus potentially represent patients who have higher income and better ability to traverse 
the health care system. As such, one would have to emphasize that the study results will 
have generalizability limitations to the general population of pancreatic cancer patients. 
Nonetheless, the information from this initial study on uncertainty and health literacy will 
provide valuable guidance for future studies.  Patients who perceive their health literacy 
to be low may also be more apt to decline participation over concern of a stigma related 
to low health literacy. 
Utilizing a cross-sectional design is deemed appropriate for this initial study on these 
concepts but it does not allow for repeated measures to assess for change in uncertainty 
levels as patients go through the phases of cancer treatment.  A future study can be done 
as a longitudinal repeated measures design to examine a patient’s the fluctuation or 
differences in uncertainty scores between the different phases of care after baseline 
information from this study has been obtained. 
Strategies to Overcome Potential Problems 
One concern to overcome is that patients may find it daunting to complete 
questionnaires during a time when they are stressed with emotional or physical 
challenges related to their illness.  The investigator will take the time to explain the 
enrollment and study process to the patient, acknowledge the patient’s valuable 
contribution, and elucidate the advances that can result from participation in the study.  It 
is also important to prevent the perception that there is judgment of skills and capabilities 
so emphasis will be placed on the overarching goal of assessing the needs of pancreatic 
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cancer patients to help providers enhance their communication skills and improve the 
way they engage patients in health care decisions. The primary investigator will stress the 
importance for health providers to understand areas for improvement in their patient 
interactions in order to promote improved partnerships with their patients. 
Human Subject Protection 
Permission to conduct the study will be requested from the Institutional Review 
Board (IRB) of The University of Texas MD Anderson Cancer Center where the study 
will be conducted. Reciprocal permission will be requested from the Committee for the 
Protection of Human Subject of University of Texas-Houston following the guidelines of 
the university in partnership with MD Anderson Cancer Center.  
Participants will be provided information on the potential risks, benefits, and the 
importance of knowledge gained from the study.  The voluntary nature of the study will 
be emphasized and it will be explained to patients and clinicians that declination of 
participation in the study will not affect clinical treatment and/or care. The clinical team, 
case management or social work team assigned to the patient will be notified if the 
patient expresses questions or concerns about increased uncertainty about their care or 
raise questions about understanding of or access to resources.    
The exclusion of patients who are non-English speaking is due to the lack of an 
instrument version translated for the assessment of health literacy in non-English 
speaking patients. As such, it would be unsuitable and detrimental to the validity of the 
study not to exclude them.     
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Confidentiality 
To ensure confidentiality, paper forms of the completed instruments will be 
secured in a locked cabinet.  All electronic files of questionnaires and the interviews will 
be kept on a password-protected secure server.  Research staff who require access to 
electronic or paper files for analysis must relinquish access when analysis is not 
occurring.  Files may only be accessed may not be kept by study personnel when not in 
use.  Digital files are identified with participant study numbers only and not with names, 
medical record numbers, or other identifying information.  When all analysis has been 
completed and all study results have been reported, the electronic and paper files will be 
stored securely in perpetuity. 
Timeline 
The study is expected to take 12 months from the time the proposal submission. The 
specific time points for each step of the study including dissertation writing and defense 
is outlined in Table 1 below. 
Table 1 
Study Timeline 
 
 
STUDY TIMELINE 
 
2016 2017 
ACTIVITY FALL SPRING SUMMER FALL 
Proposal 
Preparation 
                
Proposal 
Defense 
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IRB, CPHS 
Approval 
                
Prepare 
instruments 
                
Prepare 
Survey Sites 
                
Train Study 
Staff 
                
Recruitment/  
Data 
Collection  
                
Database 
Input 
 
                
Statistical 
Analysis 
                
Writing and 
Revisions  
                
Dissertation 
Defense 
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Uncertainty in Illness and Health Literacy in Pancreatic Cancer Patients  
Introduction 
Uncertainty in illness is the inability to determine meaning of illness-related 
events (Mishel, 1988).   It is a cognitive state that occurs when lack of cues leads to an 
inability to predict outcomes or meaningfully interpret experiences.  Health literacy is the 
degree to which individuals have the capacity to obtain, process, and understand basic 
health information and services needed to make appropriate health decisions (Cutilli & 
Bennett, 2009; Dumenci et al., 2014).  Despite a shared link to cognitive processing of 
health information suggested by their definitions, information on the association between 
uncertainty and health literacy is scarce.  Neither uncertainty nor health literacy has been 
studied with a focus on pancreatic cancer patients whose illness experience is fraught 
with complex events that predispose to uncertainty and require proficient health literacy 
to manage effectively.  This study was conducted to obtain information constructive to 
future research and patient care outcomes. 
Background 
  Studies on uncertainty in multiple cancer populations have utilized Mishel’s 
theoretical framework and suggest that uncertainty influences psychosocial adaptation 
and has been associated with diminished quality of life, emotional distress, perceived 
stress, lack of resourcefulness, and less emotional well-being (Kurita, Garon, Stanton, & 
Meyerowitz, 2013; Lin et al., 2015; Hagen et al., 2015; Zhang, 2017).  Patients with cancer 
have been found to benefit from interventions addressing uncertainty (Mishel et al., 2009; 
Gil et al., 2006).  Studies exploring uncertainty have been conducted on patients with 
breast cancer (Germino et al., 2013; Gil et al., 2006), prostate cancer (D. E. Bailey, Jr. et 
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al., 2011; D. E. Bailey, Mishel, Belyea, Stewart, & Mohler, 2004; Kazer, Psutka, Latini, 
& Bailey, 2013; Mishel et al., 2002; Mishel et al., 2009; Wallace, 2005), gynecological 
malignancies (McCorkle et al., 2009), renal malignancies (Parker et al., 2013), lymphoma 
(Elphee, 2008), and brain cancer (Cahill, Gilbert, & Armstrong, 2014; Cahill, Lin, et al., 
2014; Lin et al., 2015).  However, there are no published studies focusing on uncertainty 
in pancreatic cancer patients despite various factors in the pancreatic cancer experience 
that predispose to increased levels of uncertainty including the recalcitrant biology, grim 
prognosis, and lack of consistency in treatment sequence recommendations.  Discovery 
of baseline information is required before testing and implementing uncertainty 
interventions found effective in other cancer populations.  
Although uncertainty has been explored in patients with other aggressive 
malignancies, there are unique aspects to pancreatic cancer that warrant disease-specific 
investigation.  Pancreatic cancer is the fourth leading cause of cancer deaths in the United 
States with 55,440 new cases and 44,330 deaths in estimated in 2018 (American Cancer 
Society [ACS], 2018).  It has no established screening or prevention guidelines, no 
hallmark symptoms to promote early diagnosis and 80% of patients present with 
metastatic or locally-advanced disease at initial diagnosis (Chatterjee et al., 2012).  
Moreover, the widely-acknowledged high recurrence rate undermines confidence in 
achieving long-term survival.  The low 5-year relative survival rate for pancreatic cancer 
of 8% (American Cancer Society, 2018) carries a forbidding outlook that can cause 
patients to become overly vigilant and mistakenly interpret symptoms unrelated to 
malignancy as indicators of recurrence. 
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For patients with localized disease, the 5-year survival rate is only 32% 
(American Cancer Society, 2018).  In these patients who are eligible for curative 
resection, there is debate among experts regarding the sequence of therapy (Reynolds & 
Folloder, 2014; Evans et al., 2008; Varadhachary et al., 2008).  While the National 
Comprehensive Cancer Network (NCCN) recommends upfront surgery for potentially-
resectable disease (National Comprehensive Cancer Network, 2017), expert consensus 
and a number of phase II clinical trials support administration of neoadjuvant 
chemotherapy in selected patients with potentially-resectable, biopsy-proven 
adenocarcinoma prior to surgery (Halperin & Varadhachary, 2014; Evans et al., 2008; 
Varadhachary et al., 2008).  The lack of conformity in treatment sequence 
recommendations can lead to confusion among patients seeking information and 
guidance in making treatment decisions.  Conflicting information from clinicians on 
whether one should pursue upfront surgery versus neo-adjuvant therapy can present 
complex challenges that potentiate uncertainty and require a high level of health literacy 
to process.   
Various factors contribute to uncertainty throughout the phases of care from the 
ambiguity at initial presentation, the complexity of treatment planning, the 
unpredictability of recurrence during survivorship, and the unfamiliarity with how things 
evolve at end-of life.  A study that examined fear of recurrence in 240 patients with 
pancreatic and peri-ampullary tumors included 94 patients with pancreatic 
adenocarcinoma who completed treatment with curative intent and found that 37% of 
these patients reported frequent fearful thoughts, emotional disturbance, and functional 
impairment (Petzel et al., 2012).  In a disease with vague distressing symptoms, 
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aggressive course, and complex treatments algorithms, it is necessary to assess precursors 
and identify ways to mitigate uncertainty.  
As depicted in Figure 1, uncertainty is conceptualized as having antecedents 
namely the stimuli frame, the patient’s cognitive capacity, and structure providers that 
include patient education, social support, and credible authority (Mishel, 1988).  Stimuli 
frame comprises of  event unfamiliarity, a lack of symptom pattern, and lack of event 
congruence experienced by patients during illness (Mishel & Braden, 1988).  Structure 
providers are resources that help patients interpret variables in the stimuli frame.  
Structure providers include credible authorities, education, and social support (Mishel, 
1988).  Cognitive capacity refers to the patient’s information-processing abilities that 
enable patients to make sense of their experience (Mishel et al., 2009).  The theory 
suggests that an inability to form a cognitive structure allowing for interpretation of 
illness-related events can lead to uncertainty.   
One factor not explicitly addressed in the framework is health literacy, defined by 
the Institute of Medicine and by the US Department of Health and Human Services as the 
degree to which individuals have the capacity to obtain, process, and understand basic 
health information and services needed to make appropriate health decisions (Cutilli & 
Bennett, 2009; Dumenci et al., 2014).  Concept analyses have ascribed reading and 
numeracy skills, comprehension, capacity to use information in health care decision-
making, and successful functioning as a health care consumer as defining attributes of 
health literacy (Mancuso, 2008; Speros, 2005).  Mancuso (2008) classifies the attributes 
in three categories with the first being capacity which involves the verbal, numerical, and 
social skills essential to advocating for oneself while negotiating the health care system.  
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The second is comprehension which involves the interaction of logic, language, and 
experience essential to interpretation of information.  The third is communication which 
involves intake, processing, output, and feedback of messages through speech, writing, or 
behavior.  In addition to having these attributes, health literacy has been described as 
having three classes (Nutbeam, 2000).  Functional literacy involves reading and writing 
skills for everyday situations while interactive literacy involves advanced cognitive skills 
combined with social skills that allows a person to extract information, derive meaning 
from different forms of communication and apply such to changing circumstances 
(Nutbeam, 2000).  Critical literacy involves cognitive skills combined with social skills 
applied to critically analyze information and utilize such to exert greater control over life 
events (Nutbeam, 2000; Chinn, 2011).    
The definition and conceptualization of health literacy suggest a link to 
uncertainty but their association has not been studied in cancer patients.  A review of 
literature review did not yield any published research reports in this area.  The search 
only revealed a conference abstract describing a pilot study in 25 hospitalized older 
adults with heart failure which showed a significant correlation (r = -.415; p = .039) 
between health literacy and uncertainty (Mock & Sethares, 2013).  Another article 
discussed health literacy in advanced care planning in the context of proposing a 
theoretical model that posits improving health literacy skills and addressing domains of 
uncertainty can promote end-of-life discussions and decision making (Melhadho & 
Bushy, 2011).  The dearth of information on the relationship of these variables and the 
lack of information on uncertainty and health literacy in the pancreatic cancer population 
underscore the significance of this study.  
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Health literacy has evolved into an essential component in efforts to improve 
health outcomes and is included in Healthy People 2020 as an objective in the promotion 
of health communication (Office of Disease Prevention and Health Promotion; 2016).  
The promulgation of web-based medical information, shifts in health policy and system 
access, as well as advances in cancer care involve proficient health literacy to process 
appropriately.  According to the US Department of Education, only 12% of English-
speaking adults have proficient health literacy skills (Hepburn, 2012, US Department of 
Health and Human Services, 2010).  If this holds true in the pancreatic cancer population, 
this is detrimental to care access and delivery as patients in this population are often 
required to navigate through complex information systems and interactions with 
clinicians in order to understand their illness, access appropriate services, and participate 
effectively in decision making.   
There is a growing body of evidence suggesting that limited health literacy also 
negatively affects cancer prevention and disease management behaviors.  A study on 
1306 cancer patients found that when controlling for potentially confounding variables, 
an inverse relationship was found between health literacy and number of inpatient 
hospitalizations (β = -0.041, p =.009) as well as health literacy and total number of 
hospital days ( β = -0.028. p = .023) (Cartwright et al, 2017).  Studies in patients with 
colon cancer (Pendlimari, Holubar, Hassinger, & Cima, 2012), breast cancer (Buki, Yee, 
Weiterschan, & Lehardy, 2015; Halbach et al., 2015; Kamimura et al., 2016), cervical 
cancer (Sentell, Braun, Davis, & Davis, 2015), prostate cancer (Kayser, Hansen-Nord, 
Osborne, Tjonneland, & Hansen, 2015), lung cancer (Milne et al., 2015), and head and 
neck cancer (Koay et al., 2013) have also explored different aspects of health literacy and 
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the impact of poor literacy on outcomes.  Review of Medline, Pubmed, CINAHL, and 
PsychINFO on health literacy and cancer outcomes revealed outcome studies on patients 
with various cancers including melanoma, colorectal cancer, prostate cancer, breast 
cancer, and lung cancer.  The health outcomes investigated were quality of life (Husson, 
2015; Song, 2012; Halverson, 2015; Milne, 2015), distress (Koay, 2013), decision 
satisfaction and regret over decision outcomes (Hawley, 2008), mental well-being (Song, 
2012), medication adherence (Rust, 2011; Rust, 2012), sunscreen and sunbed use 
(Altsitsiadis, 2012), receipt of treatment including chemotherapy, reconstructive surgery, 
salvage hormone therapy, genetic counseling (Mahal, 2015; Busch, 2015: Winton, 2016), 
disease status at diagnosis (Wolf, 2006), and survivorship (Hulett, 2015).  The results of 
the quantitative studies primarily support low health literacy as having a negative 
association with health outcomes and the results of the qualitative studies suggest that 
patients perceive low health literacy as a barrier to good outcomes.   
The paucity of information on uncertainty and health literacy specific to the 
pancreatic cancer population is a hindrance to improving literacy and mitigating 
uncertainty.  Because these factors may be modifiable and essential to improving care, it 
was important to address the information and research gap.  The adapted model used for 
this study posits that health literacy could be a structure provider in the uncertainty 
framework (Figure 2). 
Objectives   
The purpose of the study was to evaluate uncertainty and health literacy in the 
pancreatic cancer patient population, determine an association between them, and 
evaluate predictors. The aims and hypotheses were:   
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1. Describe uncertainty using the Mishel Uncertainty in Illness Scale – Community 
instrument (MUIS-C) and health literacy using the Cancer Health Literacy Test – 30 
(CHLT-30) in the pancreatic cancer population  
2. Examine the association between uncertainty and health literacy in the pancreatic 
cancer patient population  
 Hypothesis: Higher levels of health literacy are significantly correlated with lower 
levels of uncertainty in pancreatic cancer patients 
3. Examine if health literacy is a significant predictor of uncertainty after adjusting for age, 
gender, race and ethnicity, education level, and disease treatment stage 
Hypothesis 3a: Health literacy is a significant predictor of uncertainty after adjusting for 
age, gender, education level, race and ethnicity, and disease treatment stage 
 Hypothesis 3b: Education level, race, and disease treatment stage are significant 
predictors of uncertainty and of health literacy in pancreatic cancer patients 
Methods 
Design  
The study was conducted using observational, cross-sectional design.  It was 
approved by the MD Anderson Cancer Center (MDACC) Institutional Review Board as 
well as by Committee for the Protection of Human Subjects of The University of Texas 
Health Science Center in Houston.   
Variables and Measurements    
Uncertainty was operationalized as the score on the MUIS-C (Appendix A), and 
health literacy operationalized as the score on the CHLT-30 (Appendix B). The MUIS-C 
has 23 items scored from 1 to 5 on a Likert scale.  The item scores are summed with a 
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higher cumulative score indicating greater uncertainty.  For the purpose of this study, 
cumulative scores on the MUIS-C were treated as continuous variables in accordance 
with developer intent.  The MUIS-C has been used extensively with cancer patients.  It 
was adapted from the 33-item Mishel Uncertainty in Illness Scale (MUIS-A), originally 
developed to evaluate uncertainty in acutely ill, hospitalized adults (Bailey et al., 
2011).  Items from the MUIS-A specifically relating to inpatient hospitalization were 
removed and the remaining questions comprise MUIS-C items.   The MUIS-A was 
assessed for content analysis and its validation information was utilized to validate the 
MUIS-C (Bailey et al., 2011).  In analyses of MUIS-C scores from 18 samples of 
chronically ill adults (total n=1068), Cronbach’s alpha exceeded 0.85 in a large majority 
of the samples indicating the reliability of MUIS-C as comparable to the 0.87 reported for 
the MUIS-A (Bailey et al., 2011).   
The 30-item CHLT-30 was created to assess literacy along the cancer health 
literacy continuum (Dumenci, et. al., 2014).  It has been tested in 1,306 adults with 
heterogenous cancer diagnoses, educational attainment, as well as health insurance and 
marital status although pancreatic cancer was not specified as a category in the most 
common cancer types ascribed to these study participants (Dumenci at al., 2014).  
Reliability evidence for the CHLT-30 was a Cronbach’s alpha of 0.88, McDonald’s 
omega of 0.89, 2-week test–retest reliability of 0.90, and 6-month test–retest reliability of 
0.90.  There was support for the unidimensional scale and all variables had significant 
factor loadings of > 0.44.  Structural equation modeling supported external validity with 
self-confidence in engaging in health decisions specified as a latent variable measured by 
two positively and two negatively worded items.  The developers indicated that it takes 
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10-15 minutes to complete the CHLT-30 electronically with a tablet device that also read 
the questions to patients.  CHLT-30 score is the total number of correct responses and 
ranges from 0 to 30 (Dumenci, et. al., 2014).   
The demographic information was obtained using a demographic form (Appendix 
C).  Education was assessed by the highest level attained with the choices being “some 
high school”, “completed high school”, “vocational school”, “some college”, “completed 
college” “some graduate school” and “completed graduate school”.  Disease treatment 
phases included “before surgery”, “within 2 years after surgery”, “within 5 years after 
surgery”, “5 years after surgery” and patients whose care did not include plans for 
resection were noted as “no surgery planned”.  The 2-year mark following surgery was 
selected to account for the high recurrence rate most frequently seen within 2 years 
following surgical resection (Heye, 2011).  The 5-year mark was selected as this 
represents a widely-acknowledged and reported survival threshold.   
In addition to the demographic and clinical information, the form also prompts 
inquiry into electronic devices used by the patient, if they use a mobile phone for 
purposes other than phone calls, and if they use the electronic health record to access 
their personal medical information.  
Participants   
Sample size justification was calculated using nQuery/nTerim version 3.0 
assigning a two-sided type I error of 5% with 80% power to detect a correlation of 0.3 
between uncertainty score and cancer health literacy score.  It was determined that a 
sample of 82 participants was needed. A total 91 were invited with allowance for 10% 
attrition.  The recruitment and accrual primarily occurred in surgical clinics.  Patients 
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presenting to MDACC Gastrointestinal Clinic were screened for eligibility by the 
primary investigator who recruited eligible patients on a consecutive basis.  
Eligibility Criteria 
Eligibility criteria included patients with a diagnosis of pancreatic 
adenocarcinoma who are 18 years or older and receiving care in an MDACC outpatient 
clinic.  Excluded were patients with pancreatic adenocarcinoma unable to speak, read, 
and write English.  Patients with pancreatic adenocarcinoma who have evidence of active 
disease or have received oncologic treatment for another primary malignancy, except 
non-melanoma skin cancer, within the past 5 years were excluded.   
Data Collection and Management 
Recruitment and data collection schedules were coordinated with the clinical 
team.  Patients were recruited, consented, and administered the questionnaires during 
clinic visits before being seen by the physician.  The voluntary nature of participation, the 
study purpose, requirements and eligibility criteria were discussed.  Informed consent 
was obtained via the electronic program used by MDACC for obtaining and storing 
consents in the electronic health record.  The patient demographic form was completed 
with the patient and thereafter, the MUIS-C and CHLT-30 were administered through 
pen and paper approach according to protocol which called for the MUIS-C to be 
completed prior to the patients’ visits with the physician.  Participants were enrolled and 
issued a participant number using the Clinical Oncology Research System (CORe) 
program which serves as the MDACC institutional research management system.  The 
primary investigator was present in clinic to collect the instruments at the conclusion of 
the patient’s participation.   
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The MUIS-C and CHLT-30 were manually scored by the primary investigator 
according to the instrument manuals.  After manual scoring, the responses were entered 
into a secure database developed using REDCap hosted by MDACC for data 
management.  Questions and response options for the MUIS-C and CHLT-30 were 
programmed into REDCap with encoded formula that automatically generate scores 
based on entered participant responses.  Every participant’s REDCap score was 
compared with their manually-derived score and the REDCap entry was saved after a 
match between manually-derived and computer-generated scores was confirmed. The 
MUIS-C items that required reverse scoring were noted and programmed accordingly.  
Instrument hard copies were stored in secure files in the primary investigator’s office.  
Data Analysis   
The REDCap database was exported to the IBM SPSS Statistics for Windows 
version 24 (IBM Corp). Significance for all tests were set at p < .05.   
Descriptive analysis was used to describe uncertainty and health literacy as 
stated in Aim 1.  Frequencies, percentages, central tendencies and variability measures 
were determined.   Because CHLT-30 scores were found to be non-normally 
distributed, differences in group scores for both MUIS-C and CHLT-30 were analyzed 
using the non-parametric Kruskal Wallis test for the sake of consistency.  Pair-wise 
testing with Bonferroni adjustment was used to ascertain where significant differences 
existed between levels of significant predictor groups. 
To address Aim 2 Spearman Rho testing was used to evaluate the correlation 
between MUIS-C and CHLT-30 scores.  This non-parametric test was selected due to the 
non-normality of the CLHT-30 scores distribution.    
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Aim 3a was addressed with multiple regression using the general linear model 
to determine if CHLT-30 score is an independent predictor of MUIS-C score 
accounting for age, gender, education, race and phase of care.  Because a clear linear 
relationship between uncertainty and health literacy was not present, CHLT-30 scores 
were transformed into categorical predictors based on quantiles.  Aim 3b tested the 
hypothesis that race/ethnicity, education level, disease treatment phase are significant 
predictors of MUIS-C and CHLT-30 scores.  General linear model was used to test 
this hypothesis.  The CHLT-30 score distribution violated the assumption of normality 
so an added measure utilizing bias corrected and accelerated bootstrap with 5,000 
sampling iterations was incorporated into the analysis.   
Results 
Demographics and clinical characteristics 
Ninety-one participants were enrolled and all had complete demographic data for 
age, marital status, racial/ethnic self-identification, gender, disease treatment phase, use 
of electronic devices and access utilization of their electronic health records.  Of these, 82 
completed both the MUIS-C and CHLT-30 and this group is used for analysis.  The 
difference in the total and the evaluable samples was due in part to some participants not 
completing the instruments before being seen by the physician.  There were also 
participants who decided not to complete instruments after starting for reasons that 
included not wanting to answer mathematic questions, being tired, instrument completion 
time being lengthy, or the health literacy questions being more difficult than anticipated.   
As summarized in Table 1, the study sample (N=82) comprised of 45 males 
(55%) and 37 (45%) females with an average age of 64.59 years ranging from 30 to 80 
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years and were predominantly married (n = 61, 74%).  Racial/ethnic self-identification 
was primarily White/Caucasian (n = 65, 79%) with Black/African American (n = 7, 8%), 
Asian (n = 4, 5%), and Latino/Hispanic (n = 7, 8%) comprising the remainder of the 
sample.  The participants’ education levels ranged from high school to completion of a 
graduate degree.   
The sample primarily consisted of patients in surgical oncology clinics and the 
majority were receiving care in anticipation of eventual surgical resection (n = 40; 48%). 
The disease treatment phase composition also included patients within 2 years after 
surgery (n = 30, 37%), within 5 years after surgery (n = 5, 6%), 5 or more years after 
surgery (n = 2, 2%), and some with no surgery planned (n = 5, 6%).  With respect to use 
of electronic devices, participants predominantly answered yes to owning a cellular phone 
(n = 81, 99%), reported using their phone for purposes other than phone calls (n = 78, 
95%), and reported utilization of the electronic health record access to look up their 
medical information (n = 76, 93%).  
This sample composition resembles that of the MDACC Surgical Oncology 
pancreatic adenocarcinoma database of patients who received care from 2000 - 2017.  Of 
8,875 patients, 56% in the database were male. Among the 8,763 patients who disclosed 
racial/ethnic self-identification, 77% were White/Caucasian and 76% of those who 
reported marital status were married.   
Table 2 includes the sample means and medians along with variability measures.  
MUIS-C mean for this sample was 46.46 (SD = 12.94) with a median of 46.5 (IQR = 21).  
CHLT-30 mean was 26.65 (SD = 3.30) with a median of 28 (IQR = 4).  
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Group Differences  
Kruskal Wallis testing revealed MUIS-C scores to be significantly different for 
levels of education (H = 15.44, p = .009), phase of care (H = 10.70, p = .030), and 
race/ethnic self-identification (H = 8.39 p = .039) as summarized in Table 3.  The 
differences are detailed in Table 5 showing that the significance in education level (H = 
44.16, p = .026) is between those whose highest educational attainment was high school 
(Mdn = 56.5, IQR = 17) and those who had some graduate schooling (Mdn = 35, IQR = 
10).  Post-hoc testing did not specify where the differences lie within phase of care.  
Significant difference in uncertainty scores within race/ethnic self-identification (H = 
38.06, p = .024) was between Latino/Hispanics (Mdn = 36, IQR = 16) and Black/African 
Americans (Mdn = 54, IQR = 11).   
CHLT-30 scores are summarized in Table 4 showing a significant difference for 
race/ethnic self-identification (H = 9.19, p = .0.27) but post-hoc pairwise testing did not 
show the source of the differences.  There was a significant difference in CHLT-30 
scores between education levels (H=18.33, p = .003) and post-hoc pairwise testing 
revealed significance (H= -29.75, p = .010) in the scores of those who completed high 
school as highest attainment (Mdn = 24.5; IQR 4) and those who completed college (Mdn 
= 28, IQR = 3).  High school graduates also had significant difference in CHLT-30 scores 
(H= -25.82,  p = .048) compared with those who attended some college (Mdn = 28, IQR = 
4).  Additionally, there was a significant difference (H = -49.20, p = .006) between high 
school graduates and those who attended some graduate school (Mdn = 29; IQR = 2) and 
a significant difference (H= -34.40, p = .010) in the scores between those who completed 
high school and those who completed a graduate degree (Mdn = 28.5, IQR = 2).  
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For the remainder of the analysis and reporting, education and disease treatment 
phase levels were re-classified to improve the balance of the group sizes.  The vocational 
school participants (n = 3) were combined with those who attended some college (n = 26) 
as these levels are proximal to each other in the order of educational attainment and there 
was no significant difference in either the MUIS-C or CHLT-30 scores between the 
levels.  They had the same CHLT-30 median of 28 and the MUIS-C score means for 
those who attended vocational school were closer to the score means of those who had 
some college than to those who completed high school (Table 3).  The order of 
educational attainment as well as the score medians and means also factored into the 
decision to combine those who attended some graduate school (n = 4) with those who 
completed graduate degrees (n = 12).  
Furthermore, due to only having two participants past the 5-year threshold in the 
disease phase category, they were combined with patients who were within 5-years after 
surgery.  Of note, Kruskal Wallis analysis with post-hoc testing found no significant 
differences in the MUIS-C or CHLT-30 scores between participants within these two 
group levels.  The phase of this new group was labeled “2 or more years after surgery”.    
Correlation 
 Spearman Rho testing yielded a significant yet weak correlation between MUIS-C 
and CHLT-30 scores with a coefficient of rs(81) = -.24 ( p = .032). Education as an 
ordinal variable was also evaluated for its association with MUIS-C and CHLT-30 and 
had a statistically significant albeit weak correlation with uncertainty (rs (81) = .23,  p = 
.038)  with health literacy (rs (81) = .38,  p < .001). 
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Predictors of Uncertainty  
General linear model was utilized to assess significant predictors of uncertainty.  
Because of the non-linear relationship (Figure 3) between uncertainty and health literacy 
scores, the health literacy scores were transformed into quantiles for regression analysis.  
Histograms in Figure 4 depicted normality in the distribution of MUIS-C scores and of 
score residuals.  Figure 5 shows the P-P Plot for distribution of residuals approximated 
linearity.  For the actual scores, skewness of .22 (SE = .27), kurtosis of -.42, (SE = .53), 
and Shapiro Wilk test (p = .24) supported normality.  Analysis of standardized residuals 
with a skewness of .16 (SE = .27), kurtosis of -.54 (SE = .53) and Shapiro Wilk (p = .47) 
also supported normality.  The Levene’s test (F = .93, p = .604) suggested homogeneity 
of variance. The profile plots of estimated marginal means for MUIS-C scores in Figure 6 
had no intersecting lines suggesting no significant interactions between independent 
variables.    
Health literacy was not a significant predictor of uncertainty (Table 6).  General 
linear model testing revealed a significant corrected model (F(12, 69) = 3.23, p = .001), 
with an adjusted R2 of .25 and ηp 2 = .360.  A summary of findings in Table 6 shows that 
accounting for age, gender, education, disease treatment phase, and health literacy, the 
significant predictors of uncertainty are education (F(3, 69) = 6.36, p <.001, ηp 2 = .217), 
and phase of care (F(3,69) = 6.52, p = .001, ηp 2 = .221).     
Table 7 specifies the differences in levels of the categorical variables compared 
with a reference in their groups.  Within disease treatment phases, there was significant 
difference in the uncertainty scores between those without surgery planned and those who 
were within 2 years after surgery (B = -19.73; 95% CI = -31.14, -8.32; p = .001; ηp2 = 
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.147).  There was also a significant difference between those receiving treatment without 
planned surgery when compared with those who were at greater than 2 years after 
surgical resection (B= -26.66; 965% CI = -40.59, -12.74; p < .001; ηp2 = .175) and those 
who were newly diagnosed but with potential for resection (B= -13.35; 965% CI = -2.42, 
-24.35; p = .018; ηp2 = .078). 
Within education levels, those whose highest attainment was completion of high 
school had a significant difference in uncertainty scores compared with each of the other 
education levels (Table 7).  A significant difference was found between high school 
graduates and those who went on to some college or vocational school (B = -18.71; 95% 
CI = -28.07, -9.35; p < .001; ηp2 = .187).  There was also a significant difference among 
high school graduates and college graduates (B = -10.11; 95% CI = -19.34, -.87; p < .032; 
ηp2 = .065) as well as high school graduates and those who attended or completed graduate 
school (B = -16.18; 95% CI = -26.49, -5.86; p = .003; ηp2 = .124). 
Predictors of Health Literacy 
Histograms of the observed CHLT-30 scores and the standardized residuals using 
general linear model revealed a non-normal distribution (Figure 7).  The observed scores 
had a skewness of -1.99 (SE = .27), kurtosis of 4.66 (SE= .53) and the Shapiro Wilk test 
of .79 (p < .001) all indicating normality violation.  The standardized residuals had a 
skewness of .028 (SE = .27), kurtosis of 2.25 (SE= .53), and a Shapiro Wilk test of 82 (p 
= .002) indicating non-normality as well.  The P-P plot showed a curvilinear pattern 
(Figure 8).  Levene’s test at F = .865 (p = .633) actually indicated equality in error 
variances.  Given the negative skew of the observed scores, logarithmic transformation 
was not effective.  Exponential, square, and cube transformation did not provide 
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appropriate correction.  Multiple regression through general linear model was therefore 
performed with bias corrected and accelerated bootstrapping (BCa) method set at 5,000 
iterations with the final results generated by SPSS indicating 4969 test samples. The 
profile plots of the estimated marginal means of the health literacy scores displayed no 
transections but rather parallel lines suggesting no significant interaction between 
independent variables (Figure 9).   
The corrected model was significant (F(8, 73) =2.74,  p = .011), with an adjusted 
R2 of .15 and ηp 2 = .231.  A summary of findings in Table 8 shows that accounting for 
age, gender, education, and treatment phase, the significant predictors of health literacy is 
education (F(3, 73) = 5.12, p = .003, ηp 2 = .174). Table 9 details the differences in the 
levels of the categorical variables in comparison to a reference and shows the results of 
bias estimates from bootstrapping along with BCa 95% confidence intervals and standard 
errors with corresponding p values. Results of BCa in Table 9 show that those whose 
highest attainment was completion of high school had a significant difference in health 
literacy scores when compared to college graduates and those who attended or completed 
graduate school.  High school graduates and those who completed college had a 
significant difference in health literacy scores without BCa at p = .003 (B = 3.60; 95% CI 
= 1.28; 5.91; ηp2 = .116) and with BCa with p = .001 (BCa 95% CI = 1.82, 5.46; SE = .98; 
bias estimate -.02).  High school graduates and those who attended or completed graduate 
school had a significant difference in health literacy scores without BCa at p = .001 (B = 
4.53; 95% CI = 2.04; 7.02; ηp2 = .153) and with BCa with p < .001 (BCa 95% CI = 2.68, 
6.55; SE = .98; bias estimate .03). 
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Discussion 
Uncertainty and Health Literacy 
Based on the Uncertainty in Illness theory, the adapted model used for this study 
(Figure 2) proposes health literacy as a structure provider that can frame unfamiliar, 
incoherent, or destabilizing health experiences. It was hypothesized that the capacity to 
obtain and process basic health information and services needed to make appropriate 
health decisions has a significant inverse correlation with the cognitive inability to give 
meaning to health-related events. 
Uncertainty levels in this study tended to be lower in reference to values 
summarized in the MUIS-C manual (N = 1068) with reported means of 42.4 – 85 and raw 
scores between 23 and 155. The mean for this present study (M = 46.44, SD = 12.94) 
approaches the lower end of the range reported in the manual.  This is likely influenced 
by the education characteristics of the present study participants that predispose towards 
lower uncertainty.  Health literacy scores trended higher in comparison with published 
research on health literacy using the CHLT-30.  A study on health literacy and 
hospitalizations reported a CHLT-30 mean of 23.68 (SD = 5.52) (Cartwright, et al., 
2017).  The validation study for the CHLT-30 involving 1,306 cancer patients reported 
mean raw scores of 23.97 (SD=5.61) for men, 24.26 (SD=5.19) for women, 20.04 
(SD=5.58) for non-Hispanic Blacks, and 26.61 (SD=3.38) for non-Hispanic Whites 
(Dumenci, et al., 2014).  These values are lower than the overall (Table 2) and 
corresponding group mean scores (Table 4) from this study which is laden with 
participants from demographic groups that predispose to higher health literacy.  
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This study found a statistically significant correlation between uncertainty and 
health literacy suggesting an inverse association where uncertainty tends to decrease as 
health literacy increases.  However, this was not a strong correlation (rs(81) = -.25, p = 
.031).  Although health literacy had a significant correlation with uncertainty, it actually 
had a stronger significant correlation with education (rs (81) = .39, p < .001) which was a 
significant predictor of uncertainty along with phase of care.  The interplay between these 
predictors likely factored in health literacy not maintaining its significance when 
adjusting for other variables.  Health literacy is multifaceted and some of its qualities and 
effects may be shared with other variables thereby diminishing its individual influence in 
the overall model.  It is interesting to consider this in light of research by Howard, 
Sentell, and Gazmararian (2006) in 3,260 participants to examine the extent to which low 
health literacy exacerbates differences between education levels and racial groups with 
respect to vaccination uptake and health status.  Howard et al., found that health literacy 
explained a small to moderate portion of the differences that would have been attributed 
to education and race if health literacy were not considered (2006).   
The results of this present study suggest while there is shared variance between 
variables, both uncertainty and health literacy have distinct characteristics that are not 
measured by other factors.  Nonetheless, their interconnections merit further studies to 
bear out their influence in the patient’s illness experience.  The sample in the present 
study is relatively small with an over-representation of participants from groups with high 
literacy scores (White/Caucasians, higher levels of education attainment) and this 
imbalance can potentially obscure otherwise significant relationships and effects on 
uncertainty.  Sample size and composition will be improved in future studies seeking to 
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clarify associations and further evaluating a prediction relationship between health 
literacy and uncertainty. 
Effect of Education 
Education level was found to be a significant predictor of uncertainty and health 
literacy in support of study hypotheses.  The finding pertaining to health literacy is in 
accordance with a study on 402 smokers (Stewart, et. al, 2013) and with a study on 2,512 
well-functioning older adults (Sudore, Mehta et al. 2006) that found low education level 
to be a significant predictor of low health literacy.  It is also consistent with the findings 
of the landmark National Assessment of Adult Literacy whereby the US Department of 
Education evaluated adult literacy involving 19,000 participants (US Department of 
Education, 2006) that found average health literacy increased with each higher level of 
education attainment.  The significant finding that education is a predictor of uncertainty 
is consistent with the summary in the MUIS-C manual that reports uncertainty scores 
decrease as education level increases (Mishel, 1997).   
 Education level was significant for MUIS-C and CHLT-30 in both Kruskal Wallis 
and general linear model testing.  Education level is a predictor that suggests those whose 
highest attainment is high school completion have higher uncertainty and lower health 
literacy compared with participants at every other level of education attainment.   
 This study sample had 72 (87%) participants with post-high school education and 
43 (52.4%) with a bachelor’s degree or higher.  For reference, only 33% of adults in the 
United States hold a bachelor’s degree or higher (U.S. Department of Commerce, 2015).  
With this education composition, this study sample trended towards lower uncertainty 
scores and higher health literacy scores.  This has practical value in helping identify 
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patients at risk for requiring special guidance in understanding their illness and engaging 
in their treatment decisions.   
The study results also highlight the importance of distinguishing between 
education and health literacy and given the tendency to sometimes attribute health 
literacy levels based on education level, this underscores the importance of examining the 
unique aspects of each variable.  
Effect of Race/Ethnicity  
Race/Ethnicity was evaluated as a predictor but inferences and generalizability are 
restricted by the study sample comprising predominantly of White/Caucasian 
participants.  According to the National Institutes of Health, the incidence of pancreatic 
cancer per 100,000 persons is 17 and 14.3 in Black/African males and females 
respectively compared with 14.2 and 11 in White males and females (National Institutes 
of Health, 2018).  This highlights the need to conduct future research in settings that will 
allow for adequate representation of the diverse groups affected by this disease.   
Phase of Care and Uncertainty 
Disease treatment phase was a significant predictor of uncertainty in this study.  
Although pancreas cancer patients report frequent concerns about unpredictability of 
disease recurrence following treatment completion (Petzel, et al., 2013), uncertainty 
trended lower in patients who were further away from the time of their surgical resection 
compared with those who were closer to initial diagnosis.  This is consistent with 
findings on evaluation of uncertainty predictors in brain tumor patients (Lin et al., 2015) 
where higher levels of uncertainty were found in patients closer to initial diagnosis.  
Pancreatic cancer patients in this study who were yet to undergo surgery had higher 
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uncertainty levels likely owing to the complexity and newness of the disease experience 
along with the concern that surgery may become a non-viable option if disease progresses 
or metastasis develops while on pre-operative treatment.  However, patients who were 
close to initial diagnosis but determined to have unresectable disease and ineligible for 
curative resection had the highest levels of uncertainty.  Surgical resection is the only 
treatment that bears potential for cure and being ineligible for curative treatment could 
predispose patients to a sense of disorganization and instability.  The complexity of end-
of-life concerns can also heighten uncertainty.  Although patients who are receiving pre-
surgery treatment are not guaranteed surgery, the possibility and hope for cure may be a 
mitigating factor for uncertainty.  These findings are consistent with the Uncertainty of 
Illness theory that describes patient’s cognitive appraisal of events as a danger or an 
opportunity (Figure 1).  Uncertainty can diminish if uncertain situations have potentially 
favorable outcomes while threatening outcomes can amplify uncertainty (Mishel, 1990).  
It was hypothesized that disease treatment phase would also have a significant 
influence on health literacy as the ability to access, understand, and utilize information 
could improve with more exposure to health information and services during the course 
of the care and treatment.   This was not supported by the study but merits further 
evaluation with a larger sample that better represents heterogeneity in disease phases.  A 
longitudinal study with repeat testing at the different phases can also be considered to 
find patterns of change while tracking the same patients for differences in health literacy 
levels through their disease course.   
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Technology Utilization 
A majority of patients in this study reported owning a mobile phone that they used 
for purposes other than phone calls and also reported using the electronic health record 
system.  This can also influence the mode of instrument administration in future studies 
with utilization of tablet or electronic administration instead of using pen and paper.  The 
association of technology proficiency and health literacy can also be formally 
investigated in future studies.       
Strengths and Limitations 
This is the first study on uncertainty and health literacy focusing on pancreatic 
cancer patients.  The study was conducted in a single-institution with participants who are 
predominantly White/Caucasian, mostly well-educated, married, and predominantly in 
the pre-surgical phase of treatment.  The study generated valuable information but its 
homogenous sample restricts inferences and extrapolations especially with respect to 
effects of race/ethnicity.  The high health literacy and low uncertainty levels in this 
sample may denote self-selection bias as participants with proficiency and resources that 
facilitate successful navigation of pathways towards receiving care in specialized centers 
may not be predisposed to high uncertainty or low health literacy.  However, the small 
sample size may have also obscured significant relationships and effects that need larger 
samples to clarify.   
The health literacy instrument was noteworthy. The CHLT-30 has advantages in 
that it is tailored for cancer patients across the health literacy continuum and is reliable 
and well-validated.  Rather than merely screening for low health literacy or measuring the 
patient’s perception of their health literacy, CHLT-30 actually measures knowledge, 
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skills, as well as confidence about engaging in health decisions.  In doing so, the CHLT-
30 can be lengthy with a degree of difficulty that can lead to bias as patients who are not 
confident with knowledge or test skills, and patients who are feeling poorly are more apt 
to defer or decline.  Instruments that are highly reliable and well validated are critical but 
length of administration time and suitability to location and setting need consideration.  
In a high-volume and busy setting that involve an interdisciplinary team managing a 
highly-complex patient population, options should be carefully considered against 
research objectives.  Future studies in similar settings should consider briefer 
instruments.  Moreover, with the suggestion that patients in this setting have a high 
degree of technology utilization, electronic administration should be considered in future 
studies.  
 Despite the small sample size and lack of generalizability especially with respect 
to race/ethnicity, this study generated constructive follow-up research questions and 
provided useful information on identifying patients who require support with 
understanding their illness experience and those who require guidance with accessing 
information and services.   
Summary and Future Directions 
In conclusion, the present study describes valuable information on uncertainty and 
health literacy in pancreatic cancer patients as well as potential predictors.  The data 
supported an inverse relationship between the uncertainty and health literacy but did not 
support health literacy as a significant predictor for uncertainty when accounting for other 
variables.  The findings were consistent with prior research in showing that education 
level is a significant predictor for both uncertainty and health literacy.  Moreover, the 
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study findings indicated support for disease treatment phase being a predictor for 
uncertainty.   
Further research is needed to delineate the effects of education, race, and health 
literacy on uncertainty.  Variables that mitigate uncertainty but disfavors enhancement of 
health literacy or vice versa also need to be studied.  The effect of race and ethnicity need 
additional investigation as the race/ethnic composition of this sample limits extrapolation.  
Future studies will require larger sample sizes with adequate representation of 
demographic and clinical groups in order to uncover and clarify significant relationships 
that will help patients understand their illness experience and enhance knowledge, skills, 
as well as access to information and services.    
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Table 1 
Demographic Characteristics 
Demographic Characteristic MUIS-C AND CHLT-30 
 
N = 82 
 
  
n (%) 
 
Age (mean) (range) 64.59 (50) 
Gender  
 Male 45 (55%) 
 Female  37 (45%) 
Marital Status  
 Married 61 (74%) 
 Single 8 (10%) 
 Widowed 9 (11%) 
 Married; currently separated 1 (1%) 
 Unmarried; with significant other 3 (4%) 
Racial and Ethnic Self-Identification  
 Asian 4 (5%) 
 Black, African-American 7 (8%) 
 Latino, Hispanic 6 (7%) 
 White, Caucasian 65 (79%) 
 Native American - 
 Native Hawaiian, Pacific Islander - 
Level of Education  
 Some High School - 
 Completed High School 10 (12%) 
 Vocational School 3 (4%) 
 Some College 26 (32%) 
 Completed College 27 (33%) 
 Some Graduate School 4 (5%) 
 Complete Graduate Degree 12 (15%) 
Phase of Care  
 Before Surgery  40 (49%) 
 Within 2 Years After Surgery 30 (37%) 
 Within 5 Years After Surgery 5 (6%) 
 5 or More Years After Surgery 2 (2%) 
 No Surgery Planned 5 (6%) 
Do you have cellular phone?  
 Yes 81 (99%) 
 No 1 (1%) 
Do you use cellular phone for purposes other than calls?  
 Yes 78 (95%) 
 No 4 (5%) 
Do you use electronic health record to access your medical 
information? 
 
 Yes 76 (93%) 
 No 6 (7%) 
 
Note. MUIS-C = Mishel Uncertainty in Illness Scale –Community; CHLT-30 = Cancer 
Health Literacy Test.  
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Table 2 
 
MUIS-C and CHLT-30 Descriptive Statistics 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note.  MUIS-C = Mishel Uncertainty in Illness Scale –Community; CHLT-30 = Cancer 
Health Literacy Test 30; SE = standard error; CI = confidence interval; IQR = inter-
quartile range.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 MUIS-C Scores             CHLT-30 
N Valid 82 82 
Missing 0 0 
Mean 46.46 26.65 
Std. Error of Mean 1.43 .365 
95% CI Lower 43.62 25.95 
Upper 49.28 27.37 
Median 46.5 28.00 
Std. Deviation 12.938 3.301 
Range 60 16 
Minimum 23 14 
Maximum 83 30 
IQR 21 4 
Skewness .22 (SE = .27) -1.99 (SE =. 27) 
Kurtosis -.42 (SE = .53) 4.65 (SE =.53) 
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Table 3 
 
MUIS-C Results by Groups  
 
Note. P values generated using Kruskal Wallis analysis, H values represent Kruskal Wallis statistics.  MUIS-C = Mishel Uncertainty in 
Illness Scale –Community. n = sample size, SD = standard deviation; CI = confidence interval; Min = lowest score; Max = highest 
score; IQR = inter-quartile range; H = Kruskal Wallis test statistic; Significance p < 0.05 
 
 
Demographic Characteristic n Mean SD 95% CI Min Max Median IQR P value 
Gender         (H = .17;  p =.678) 
 Male 45 47.07 12.98 43.17 - 50.97 25 83 47 21  
 Female  37 45.73 12.99 41.4 – 50.06 23 74 46 21  
Marital Status         (H = 1.72;  p =.787) 
 Married 61 45.72 12.48 42.52 - 48.92 23 70 46 24  
 Single 8 52.5 17.96 37.48 - 67.52 25 83 53 26  
 Widowed 9 47.89 13.33 37.64 – 58.13  26 74 51 14  
 Married; currently separated 1  45.69  
 Unmarried; w/ significant other 3 44.33 5.03 31.83 – 56.84 39  49 45 .  
Racial, Ethnic Self-Identification         (H = 8.39;  p =.039) 
 Asian 4 44.50 6.25 34.56 – 54.44 37 52 44.5 12  
 Black, African-American 7 56.14 7.73 48.99 – 63.3 48 70 54 11  
 Hispanic 6 36.5 9.27 26.77 – 46.23 26 50 36 16  
 White, Caucasian 65 46.46 13.32 43.16 – 49.76 23 83 46 22  
Level of Education         (H = 15.44; =.009) 
 Completed High School 10 59 14.20 48.84 – 69.16 31 83 56.5 17  
 Vocational School 3 34.67 10.26 9.17 – 60.16 26 46 32 .  
 Some College 26 44.19 12.65 39.08 – 49.30 23 70 45 22  
 Completed College 27 47.89 11.02 43.53 – 52.25 27 67 48 20  
 Some Graduate School 4 34 5.29 25.58 – 42.42 27 39 35 10  
 Complete Graduate Degree 12 44.83 11.38 37.61 – 52.06 25 65 43 16  
Phase of Care         (H = 10.70; p =.030) 
 Before Surgery  40 49.08 12.69 44.97 – 53.08 27 83 49.5 17  
 Within 2 Years After Surgery 30 42.57 12.54 37.88 – 47.25 23 67 42 20  
 Within 5 Years After Surgery 5 40 9.43 28.29 – 51.71 31 56 37 14  
 5 or More Years After Surgery 2 39 18.38 -126.18 – 204.18 26 52 39 .  
 No Surgery Planned 5 58.4 8.26 48.14 – 68.66 50 70 59 16  
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Table 4 
 
CHLT-30 Results by Groups  
 
 
Note. P values generated using Kruskal Wallis analysis, H values represent Kruskal Wallis statistics.  CHLT-30 = Cancer Health 
Literacy Test 30; n = sample size, SD = standard deviation; CI = confidence interval; Min = lowest score; Max = highest score; IQR 
= inter-quartile range; H = Kruskal Wallis test statistic; significance p < 0.05 
Demographic Characteristic N Mean SD 95% CI Min Max Median IQR P value 
Gender         (H = 1.94;  p =.164) 
 Male 45 26.4 3.16 25.45 – 27.35 14 30 27 4  
 Female  37 26.95 3.48 25.79 – 28.11 14 30 28 3  
Marital Status         (H = 8.90;   p =.063) 
 Married 61 27.02 3.01 26.25 - 27.79 14  30 28 3  
 Single 8 24 3.07 21.43 – 26.57 19 28 25 5  
 Widowed 9 26 4.87 22.25 – 29.75 14 30 28 4  
 Married; currently separated 1    29 
 Unmarried w/ significant other 3 27.33 2.08 22.16 –  32.50 25 29 28 4  
Racial and Ethnic Self-Identification        (H = 9.19;   p =.027) 
 Asian 4 26.25 2.22 22.72 – 29.78 24 29 26 4  
 Black, African-American 7 21.71 7.09 15.16 – 28.27 25 30 19 15  
 Hispanic 6 24.17 3.55 20.45 – 27.89 18 28 24.5 6  
 White, Caucasian 65 27.43 2.00 26.94 – 27.93 21 30 28 3  
Level of Education         (H = 18.33; p = .003)   
 Completed High School 10 23.6 2.72 21.66 – 25.54 18 27 24 4  
 Vocational School 3 27.67 .57 26.23 – 29.10 27 28 28 1  
 Some College 26 25.88 4.63 24.01 – 27.76 14 30 28 4  
 Completed College 27 27.52 1.63 26.88 – 28.16 25 30 28 3  
 Some Graduate School 4 29.00 .82 27.7 – 30.30 28 30 29 2  
 Complete Graduate Degree 12 27.83 1.85 26.66 – 29.01 24 30 28 2  
Phase of Care         (H = 1.97;   p  =.580) 
 Before Surgery  40 25.95 4.06 24.65 – 27.25 14 30 27.50 5  
 Within 2 Years After Surgery 30 27.57 1.87 26.87 – 28.26 24 30 28 3  
 Within 5 Years After Surgery 5 26.80 2.39 23.84 – 29.76 23 29 28 4  
 5 or More Years After Surgery 2 28 . . 28 28 28 .  
 No Surgery Planned 5 26 4.06 20.96 – 31.04 19 29 28 6  
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 Table 5 
Levels Within Predictor Categories with Significant Differences on Kruskal Wallis Testing 
 H SE Std. Test 
Statistic 
Sig Adj. Sig 
MUIS-C SCORES 
EDUCATION      
 Completed HS/ Some Grad School 44.16 14.08 31.26 .002 .026 
RACE      
 Latino – Black 38.06 13.24 2.87 .004 .024 
PHASE OF CARE * 
 
     
CHLT-30 SCORES 
RACE*      
EDUCATION      
 Completed HS/Some College -25.82 8.76 -2.95 .003 .048 
 Completed HS/Completed College -29.75 8.71 -2.42 .001 .010 
 Completed HS/Some Grad School -49.20 13.92 -3.54 .000 .006 
 Completed HS/Completed Grad School -34.41 10.07 -3.42 .001 .010 
 
Note.  * Variable was significant on Kruskall Wallis analysis but post-hoc testing did not reveal differences Post-hoc pair-wise testing 
was performed on all variables. Table only includes information on the pairs with  significant differences; .  CHLT-30 = Cancer 
Health Literacy Test 30; MUIS-C = Mishel Uncertainty in Illness  Scale –Community; H = Kruskal Wallis test statistic; SE = standard 
error; Std = standardized; Adj. Sig =  Bonferroni adjusted; Sig = p < .05   
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Table 6 
General Linear Model Tests of Between Subjects – Effects with MUIS-C as Dependent Variable 
 
Type III Sum of 
Squares df F Sig. 
Partial Eta 
Squared 
Corrected Model 4865.51 12 3.23 .001 .360 
Intercept 3507.30 1 27.96 .000 .289 
EDUCATION 2395.09 3 6.36 .001 .217 
PHASECARE 2453.72 3 6.52 .001 .221 
SEXGENDER .01 1 .00 .993 .000 
AGE 4.46 1 .04 .851 .001 
CHLT-30  97.66 4 .20 .940 .011 
Error 8656.88 69    
Total 190548.00 82    
Corrected Total 13522.39 81    
 R Squared = .360 (Adjusted R Squared = .25) 
 
Note. df = degrees of freedom; MUIS-C = Mishel Uncertainty in Illness; Scale –Community;  
CHLT-30 = Cancer Health Literacy Test 30  
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Table 7 
 
General Linear Model Significant Differences in MUIS-C Scores Within Independent Variables 
 
  Corrected Model Summary  
 
 
Adjusted R2 
.248 
F (df) 
3.23 (12,69) 
Sig. 
p = <.001 
Partial Eta 
Squared 
 ηp2  = .360 
Significant Differences in MUIS-C Scores Within Independent Variables 
 
 
 
 
 
B 
 
 
     SE 
 
 
 
     t 
95% Confidence Interval  
 
 
p 
 
   ηp2 Lower Bound Upper Bound 
Highest Education Attainment   
Completed High School 
(Reference) 
       
Vocational/Some College -18.71 4.69 -3.99 -28.07 -9.35 .000 .187 
Completed College -10.11 4.63 -2.18 -19.34 -.87 .032 .065 
Some or Completed Grad 
School 
-16.18 5.17 -3.13 -26.49 -5.86 .003 .124 
Gender 
Female (Reference)        
Male   .011 2.73 .00 -5.44 5.46 .997 .000 
Disease Treatment Phase 
No Surgery Planned  
(Reference) 
       
Before Surgery -13.35 5.52 -2.42 -24.35 -2.35 .018 .078 
Within 2 years After Surg  -19.73 5.72 -3.45 -31.14 -8.32 .001 .147 
Greater 2 years from Surg   -26.66 7.00 -3.82 -40.59 -12.74 .000 .175 
CHLT-30 SCORE        
CHLT -30 Score 30         
CHLT-30 Score  14 -25  1.14 4.92 .23 -8.68 10.95 .818 .001 
CHLT -30 Score  26-27 -1.21 5.01 -.24 -11.19 8.80 .812 .001 
CHLT -30 Score  28  .21 5.00 .04 -9.76 10.18 .967 .000 
CHLT -30 Score  29  -1.94 4.81 -.40 -11.53 7.66 .688 .002 
AGE .03 .14 .19 -.24 .29 .851 .001 
 
Note. df = degrees of freedom; B = unstandardized coefficient; ηp2 = partial eta squared; Sig = significance; p < .05 
MUIS-C = Mishel Uncertainty in Illness Scale –Community; CHLT-30 = Cancer Health Literacy Test 
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Table 8 
 
General Linear Model Tests of Between Subjects – Effects with CHLT-30 as Dependent Variable 
 
Source 
Type III Sum 
of Squares df F Sig. 
Partial Eta 
Squared 
Corrected 
Model 
204.01 8 2.74 .011 .231 
Intercept 1099.63 1 118.27 .000 .618 
EDUCATION 142.84 3 5.12 .003 .174 
PHASECARE 27.11 3 .97 .411 .038 
SEXGENDER 11.68 1 1.26 .266 .017 
AGE 6.82 1 .73 .395 .010 
Error 678.73 73    
Total 59105.00 82    
Corrected Total 882.74 81    
R2 = .23; Adjusted R2 - .15     
 
 
Note. df = degrees of freedom; B = unstandardized coefficient; ηp2 = partial eta squared; Sig = significance; p < .05 
CHLT-30 = Cancer Health Literacy Test 30  
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Table 9 
General Linear Model Significant Differences in CHLT-30 Scores Within Independent Variables 
    Corrected Model Summary        Bootstrap Results 
Adjusted R2 
 
 
.15 
Type II Sum of Squares 
 
 
204.01 
F (df) 
 
 
2.74 (8,73) 
Sig. 
 
 
p = <.011 
Partial Eta 
Squared 
 
ηp2   = .231 
 
 Differences in CHLT-30 Scores Within Independent Variables  
  
B 
 
SE 
 
t 
95% 
Confidence 
Interval 
  
 p 
 
 
ηp2 
 
Bias 
 
SE 
 
P 
BCa 95%  
Confidence 
Interval Lower  
Bound 
Upper  
Bound 
Lower  
Bound 
Upper  
Bound 
Highest Level of Educational Attainment      
Completed High School (Reference)            
Vocational/Some College 2.31 1.18 1.96 -.04 4.67 .054 .050 .01 1.32 .095 -.36 4.91 
Completed College 3.60 1.16 3.09 1.28 5.91 .003 .116 -.02 .98 .001 1.82 5.46 
Some/Completed Grad School 4.53 1.25 3.63 2.04 7.02 .001 .153 .03 .98 .000 2.68 6.55 
Gender      
Female (Reference)             
Male -.81 .72 -1.12 -2.25 .63 .266 .017 -.04 .79 .315 -2.42 .57 
Phase of Care/Treatment 
. 
. 
. 
. 
. 
. 
     
No Surgery Planned (Reference)             
Before Surgery -.25 1.50 -.17 -3.23 2.73 .867 .000 .003 2.19 .918 -3.67 4.09 
Within 2 years After Surgery .94 1.54 .61 -2.13 4.00 .544 .005 .03 2.08 .665 -2.23 5.23 
2 years After Surgery  1.04 1.88 .55 -2.70 4.78 .582 .004 .03 2.18 .631 -2.45 5.53 
 
Note. Bias corrected and accelerated bootstrap calculation was set at 5,000 iterations with SPSS generating results based on 4969 
samples.  df = degrees of freedom; B = unstandardized coefficient; ηp2 = partial eta squared; Sig = significance; p < .05 
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Figure1.  Mishel’s Uncertainty in Illness Model.  Adapted from Uncertainty in Illness (Mishel, 1998) 
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Figure 2.  Antecedents to Uncertainty in Illness.  Adapted from Uncertainty in Illness (Mishel, 1998) 
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Figure 3.  Scatterplot for MUIS-C and CHLT-30 Scores.  MUIS-C = Mishel Uncertainty in Illness Scale –Community; CHLT-30 = 
Cancer Health Literacy Test 30 
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Figure 4. Histogram of MUIS-C observed scores and Histogram of MUIS-C Standardized Residuals. A = histogram of MUIS-C raw 
scores; B = histogram of MUIS-C standardized residuals. MUIS-C = Mishel Uncertainty in Illness Scale –Community 
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Figure 5. P-P Plot of Standardized Residuals for MUIS-C Scores.  Probability plot of MUIS-C standardized residuals; MUIS-C = 
Mishel Uncertainty in Illness Scale –Community. 
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Figure 6. Estimated Marginal Means Profile Plots for MUIS-C.  Covariates appearing in the model are evaluated at the following 
values: AGE = 64.59, chlt30_score = 26.65. No intersecting lines suggesting interaction were noted.  
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Figure 7. Histogram of CHLT-30 observed scores and Histogram of CHLT-30 Standardized Residuals. A = histogram of CHLT-30 
raw scores; B = histogram of CHLT-30 standardized residuals. CHLT-30 = Cancer Health Literacy Test 
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Figure 8. P-P Plot of Standardized Residuals for CHLT-30 Scores.  Probability plot of standardized CLHT-30 residuals 
CHLT-30 = Cancer Health Literacy Test 
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Figure 9. Estimated Marginal Means Profile Plots for CHLT-30. Covariates appearing in the model are evaluated at the following 
values: AGE = 64.59. No intersecting lines suggesting interaction were noted.  
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1.0 Objectives 
 
1. Describe uncertainty in the pancreatic cancer patient population using the Mishel 
Uncertainty in Illness Scale – Community instrument (MUIS-C) 
2. Describe health literacy using the Cancer Health Literacy Test – 30 (CHLT-30) and its 
association to uncertainty in the pancreatic cancer patient population  
 Hypothesis 2a: Higher levels of health literacy are significantly correlated with lower 
levels of uncertainty in pancreatic cancer patients 
 Hypothesis 2b: Health literacy is an independent predictor of uncertainty in pancreatic 
cancer patients after adjusting for age, sex, race, education level, and disease treatment 
stage  
3. Examine if age, sex, race, education level, and disease treatment stage are significant 
predictors of uncertainty and health literacy in the pancreatic cancer population 
 Hypothesis 3a: Education level, race, disease treatment stage are significant predictors 
of uncertainty and of health literacy in pancreatic cancer patients 
 Hypothesis 3b: Age and sex are not significant predictors of uncertainty or of health 
literacy in pancreatic cancer patients 
 
The primary aim is to determine if a significant correlation exists between of uncertainty 
and health literacy in the pancreatic cancer population (hypothesis 2a). As neither 
uncertainty nor health literacy has been studied in this population, exploratory aims are to 
describe uncertainty and health literacy in pancreatic cancer patients, and to examine for 
significant predictors.   
 
2.0 Rationale 
 
Pancreatic cancer has aggressive biology, vague and distressing symptoms, and lacks 
expert agreement on treatment guidelines for patients with potentially-curable, resectable 
disease. For patients undergoing treatment, there is debate even among experts regarding 
the sequence of therapy for patients with resectable disease (Evans et al., 2008; 
Varadhachary et al., 2008).  The National Comprehensive Cancer Network (NCCI) 
recommends upfront surgery for potentially-resectable pancreatic cancer but expert 
consensus and a number of phase II clinical trials support administration of neoadjuvant 
chemotherapy in selected patients with biopsy-proven carcinoma prior to surgery 
(Halperin & Varadhachary, 2014).  Even for patients who complete treatment, the 
widely-acknowledged high recurrence rate undermines confidence in having achieved 
long-term survival or cure. The 5-year survival rate for pancreatic cancer remains low at 
7% (ACS, 2016) and approximately 80% of patients undergoing resection with curative 
intent develop distant metastasis or local recurrence within five years of surgery 
(Halperin & Varadhachary, 2014).  With a grim prognosis, patients can become overly 
vigilant and mistakenly interpret symptoms unrelated to malignancy as indications of 
disease recurrence. All of these factors contribute to uncertainty, defined as a cognitive 
state wherein there is inability to give meaning to illness events (Mishel, 1988, Mishel & 
Braden, 1988, Mishel, et al., 2009).  ).  It is conceptualized by Mishel within the 
Uncertainty of Illness Theory as a cognitive state that occurs when the decision maker 
unable to assign values to events or is unable to predict outcomes due to cues being 
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lacking or insufficient (Bailey,  et al., 2011).  The framework describes that individuals 
cognitively process illness stimuli then through primary appraisal, derive meaning. 
Uncertainty has been studied in many cancer populations (Bailey et al., 2011; Cahill et 
al., 2014; Elphee, 2008; Germino et al., 2013; McCorkle et al., 2009; Mishel et al., 2002; 
Mishel et al., 2009; Parker et al., 2013) but it has not been studied in pancreatic cancer 
patients.  
 
Uncertainty is linked to poor outcomes (Lin et al., 2015) and one factor that can 
potentially mitigate uncertainty is health literacy, defined as the capacity to obtain, 
process, and understand health information and services needed to make appropriate 
health decisions (Dumenci, 2014). Limited health literacy is also associated with 
unfavorable outcomes in cancer patients (Mahal, 2015; Busch, 2015: Winton, 2016; 
Hawley, 2008; Koay, 2013) and low health literacy is perceived by cancer patients as a 
barrier to good outcomes (Rust, 2011; Rust, 2012). Unfortunately, health literacy has not 
been studied either with a focus on pancreatic cancer patients whose illness experience 
require navigation of complex information and services pathways in order to engage 
successfully in treatment decisions.  
 
Despite the shared link to information processing suggested by their definitions, the 
relationship between uncertainty and health literacy has not been studied in cancer 
patients and has not been studied individually in pancreatic cancer patients. This study 
planned within a framework adapted from Mishel Uncertainty Theory will address these 
gaps (Mishel, 1988, Mishel & Braden, 1988, Mishel, et al., 2009). The model adapted 
from MIshel’s orginal framework and focused on the antecedent portion of the original 
model is illustrated in Figure 1.  
 
Figure 1. Antecendents of Uncertainty in Pancreatic Cancer Patients 
Adapted from Mishel’s Uncertainty in Illness Theory (Mishel, 1988). 
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In this model, Event Stimuli represents the events during the different phases of diagnosis 
and disease management that the patients may experience. The Structure Providers 
represent factors that can help the patient interpret illness events. Patient Characteristics 
include the patient’s demographics that include age, education level, sex, and race. 
The study will examine demographic and factors to evaluate if there are predictors that 
can guide future research and identification of individuals who are more susceptible to 
uncertainty. Prior health literacy assessment in 1,306 cancer patients found no significant 
mean difference between men and women (p=.247) but the scores among African 
Americans were found to be significantly lower (p < .0001) than White participants 
(Dumenci et al., 2014).  This study found that participants with limited health literacy 
consisted of an overrepresentation of African-Americans, patients who were 
undereducated, and patients with lower income (Dumenci et al., 2014).  Meanwhile 
aggregate data on different population subgroups described in the Uncertainty in Illness 
Scales Manual indicate no difference in the mean scores based on sex or age but that 
scores decrease with an increase in level of education (Mishel, 1997).  These 
demographic variables will be evaluated as this can influence the design and 
implementation of future studies and intended population of intervention programs.  
Moreover, patient uncertainty has been found to vary according to disease treatment stage 
with a brain tumor population study showing variation depending on treatment status 
with newly diagnosed patients and patients on active treatment having high levels of 
uncertainty (Lin et al., 2015). This will be assessed in pancreatic cancer patients to 
facilitate and promote communication between clinicians and patients when making 
health care decisions.  
  
3.0 Eligibility of Subjects 
 
INCLUSION CRITERIA  
1. Patients with a diagnosis of biopsy-proven pancreatic adenocarcinoma who are 
being treated in an Ambulatory Outpatient Clinic at MD Anderson Cancer Center 
Main Campus.  
2. Patients who meet the above criteria and are 18 years of age or older 
 
EXCLUSION CRITETRIA  
1. Patients who have a history or current diagnosis of another primary malignancy 
other than pancreatic adenocarcinoma  
2. Patients unable to speak, read, or write in English will be excluded because the 
study instruments are in English 
3. Pancreatic adenocarcinoma patients who are under 18 years of age 
4.0 Research Plan and Methods 
 
The study is designed as an observational, cross-sectional study seeking to describe 
uncertainty in illness and health literacy in the pancreatic cancer population and explore 
the relationship between these variables.  Given the absence of prior studies on 
uncertainty and health literacy in pancreatic cancer patients, this design is appropriate as 
an exploration that can provide groundwork for future research.   Written approval prior 
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to the initiation of the study will be obtained from the Institutional review Board of MD 
Anderson. The principal investigator (PI) will provide training to study staff prior to data 
collection. 
 
Recruitment:  
Patients who meet the eligibility criteria will be invited to participate in the study when 
they present for a clinic visit by the investigator and will be approached to obtain 
informed consent.  This study and the recruitment will be conducted in the outpatient 
clinic during a patient’s scheduled visit to the clinic. Patients will not be required to 
report to clinic for the purpose of study participation on days when they otherwise do 
not have a scheduled visit for cancer treatment or follow-up.  
 
Collaboration and coordination with the clinic team seeing the patients will be 
established for the study prior to beginning screening, recruitment, and enrollment. The 
eligibility review and recruitment will be as follows: 
 
1. Primary investigator will pre-screen the patients scheduled to attend pancreatic 
cancer clinic in preparation for the research study  
2. Primary investigator will send the list of eligible patients to the clinic team and 
obtain permission to recruit the patients in clinic on the day of their visits  
3. Primary investigator will approach the eligible patients in clinic on a consecutive 
basis to explain the study and invite their participation 
4. The primary investigator will explain the Informed Consent process and voluntary 
nature of study participation and address patient questions 
5. The principal investigator will obtain signatures for Informed Consent 
6. A copy of the completed consent will be kept in the electronic health record 
system  
7. A copy of the completed consent will be offered to the patient and given to those 
who want to keep a copy for their personal records  
 
 
Registration: 
 
Enrolled patients will be registered into the Clinical Oncology Research System (CORe) 
which serves as the MD Anderson Cancer Center institutional patient data management 
system. 
 
Data Collection:  
The questionnaires will not contain identifiers but will only have a participant number. 
Enrolled patients will complete the instruments in the clinic. Collaboration and 
coordination with the clinic team seeing the patients will be established for the study prior 
to beginning screening, recruitment, and enrollment.  
 
The participants will complete the questionnaires in the clinic room or waiting area before 
they are seen by the physician during their visit. 
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1. Data will be collected by paper and pencil surveys with the investigator entering 
information into the web-based REDCap application hosted by MD Anderson 
Cancer Center (https://redcap.mdanderson.org) 
2. The investigator or a clinical research staff will be available in clinic during the 
time the patient is completing the instruments 
3. The investigator or research staff may not provide any answers to the specific 
questions on the questionnaire but can address questions about study participation 
or the process of form completion  
4. Only the patient may complete the form. Family members or patient companions 
to the visit may not answer or complete the forms. If there are deficits that makes 
reading the questionnaire or writing the responses difficult, the questionnaire can 
be read to the patient by the research staff or the patient companion and the 
responses recorded according to the patient response 
5. Investigator or research staff will review the forms to ensure completeness or that 
the participant has responded to all the items that want to answer. The primary 
investigator will keep the completed forms to a secure location in the primary 
investigator’s office  
6. Participants will not take home their questionnaires for completion. If a 
participant does not complete his or her participation while in clinic, the 
participant will not be included in the sample to be analyzed. 
 
Recruitment and informed consents is anticipated to take 20 minutes while the time to 
complete the instruments is anticipated to take approximately 20 minutes with a total 
participation time of 40 minutes.  The primary investigator will enter the data into the 
secure RedCap database. Data entry and instrument scoring will be conducted according 
to the instrument manuals and study protocol prepared for the study.   
 
INSTRUMENTS 
 
The Mishel Uncertainty in Illness Scale – Community Form (MUIS-C) will be used to 
measure uncertainty.  The MUIS-C has 23 items scored 1 to 5 on a Likert scale.  The item 
scores are summed with a higher cumulative score indicating greater uncertainty.  The 
MUIS-C has been used extensively with cancer patients.  The MUIS-C was adapted from 
the 33-item Mishel Uncertainty in Illness Scale (MUIS-A), originally developed to 
evaluate uncertainty in acutely ill, hospitalized adults (Bailey et al., 2011).  Items from 
the MUIS-A specifically relating to inpatient hospitalization were removed and the 
remaining questions comprise the items for the MUIS-C version.  The MUIS-A was 
developed through expert analysis and validation of the MUIS-A was utilized to support 
the validity of the MUIS-C (Bailey et al., 2011).  In analyses of MUIS-C scores from 18 
samples of chronically ill adults (total n=1068), Cronbach’s alpha exceeded 0.85 in a 
large majority of the samples indicating the reliability of MUIS-C as comparable to the 
0.87 reported for the MUIS-A (Bailey et al., 2011).  Scores can range from 23 to 115 
with a higher score indicating higher uncertainty. There is no categorical delineation 
regarding what is considered as “low”, “moderate” or “high” uncertainty.    
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The Cancer Health Literacy Test – 30 (CHLT-30) (Dumenci, et. al., 2014) will be used to 
measure health literacy.  The 30-item CHLT-30 was created to assess literacy along the 
cancer health literacy continuum.  Its development was described in a publication of a 
study involving 1,306 adults with heterogenous cancer diagnoses, educational attainment, 
and health insurance and marital status.  Pancreatic cancer was not listed as a category 
among the 11 diagnostic cancer types represented by the participants in the study sample.  
The reliability evidence for the CHLT-30 was a Cronbach’s alpha of 0.88, McDonald’s 
omega of 0.89, 2-week test–retest reliability of 0.90, and 6-month test–retest reliability of 
0.90.  There was support for the unidimensional scale and all variables had significant 
factor loadings of > 0.44.  Structural equation modeling supported external validity with 
self-confidence in engaging in health decisions specified as a latent variable measured by 
two positively and two negatively worded items.  The test score is the total number of 
correct responses and ranges from 0 to 30.  The instrument response time ranges from 10-
15 minutes (Dumenci, et. al., 2014). 
A Patient Demographic Form will be utilized to record demographic information 
including age, sex, education level, race, and disease treatment stage.    
5.0 Statistics and Justification of Sample Size 
 
The sample size calculation is based on the primary aim to determine a correlation 
between uncertainty and health literacy. An estimated total of up to 91 patients will be 
invited to participate.  With an anticipated response rate of approximately 90%, an 
analyzable sample size of 82 will be produced. The primary objective is to collect the 
uncertainty and health literacy information in pancreatic cancer patients and assess the 
correlation between uncertainty and health literacy. The primary endpoints are the 
Mishel uncertainty scores, which is defined as the summation of all the questions 
scores and the cancer health literacy test scores which is defined as the number of 
questions that the patient answers correctly.  With 82 patients in total, given the two-
sided type I error of 5%, we will have an 80% power to detect a Pearson’s correlation 
of 0.3 between uncertainty score and cancer health literacy score. nQuery/nTerim 
version 3.0 was used for the sample size justification. 
 
Questionnaire scores will be calculated based on standardized manuals associated with 
each survey instrument.  Descriptive statistics will be used to summarize scores of the 
questionnaires according to respective scoring manuals for each of the measures. The 
distribution of each continuous variable will be summarized by its mean, standard 
deviation, median, and range.  The distribution of each categorical variable will be 
summarized in terms of its frequencies and percentages.  The difference in uncertainty 
and health literacy scores will be assessed between groups (e.g. gender, education 
levels) by a two-sample t-test or ANOVA if the data is normally distributed; otherwise 
a Wilcoxon rank sum or Kruskal-Wallis test will be used.  The association between 
uncertainty scores and health literacy score will be examined by Pearson correlation. 
To identify factors associated with uncertainty or health literacy scores of the survey 
measures, for example, the patient education level, age, race, and gender, multivariate 
linear regression will be performed to examine their effects.  
Specifically, the hypotheses testing and anticipated results are as follows:  
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1. Describe uncertainty in the pancreatic cancer patient population using the MUIS - 
this primary, exploratory aim will assessed using Descriptive Analysis and Analysis 
of Variance (ANOVA)    
 
2. Describe health literacy using the CHLT-30 and its association to uncertainty in the 
pancreatic cancer patient population  
Hypothesis 2a: Higher levels of health literacy are significantly correlated with 
lower levels of uncertainty in pancreatic cancer patients - Pearson product 
moment correlation coefficient will be calculated. Kendall’s tau b or Spearman rho 
will be used if there is not a linear relationship or normal distribution. The 
anticipated result will be an inverse linear association between uncertainty and 
health literacy.  
Hypothesis 2b: Health literacy is an independent significant predictor of 
uncertainty in pancreatic cancer patients after adjusting for age, sex, education 
level, race, disease treatment stage - Health literacy will be included in 
multivariate regression to evaluate if it is a significant predictor of uncertainty after 
adjusting for other variables under study. 
 
3. Examine significant demographic predictors of uncertainty and health literacy in the 
pancreatic cancer population 
Hypothesis 3a: Education level, race, disease treatment stage are significant 
predictors of uncertainty and of health literacy in pancreatic cancer patients – 
Multiple linear regression will be performed to determine if these variables are 
significant predictors for uncertainty and multivariate regression will be also be 
performed to assess if they are significant predictors for health literacy as well. The 
anticipated results will be that education level, race, and disease treatment stage will 
be significant predictors for both health literacy and uncertainty. 
Hypothesis 3b: Age and sex are not significant predictors of uncertainty or of 
health literacy in pancreatic cancer patients - Multivariate regression will be 
performed to determine if age and sex are significant predictors for uncertainty and 
multivariate regression will be also be performed assess if they are significant 
predictors for health literacy as well. The anticipated results will be that neither age 
not sex will come out as significant predictors for either uncertainty or health 
literacy.   
 
6.0 Informed Consent Process   
Participants 18 years of age and older will be consented in the clinic during scheduled 
visits. They will be consented by the study PI or by authorized, trained research personnel 
listed on the Delegation of Authority. This study has minimal risks and does not provide 
treatment. 
 
Patients will be given the opportunity to review study documents and ask questions, and 
will be given time to consider their participation prior to signing the consent. This study 
is limited to English-speaking patients, due to the instruments only being available in 
English, therefore, patients who are unable to read, write, and understand English will not 
be consented to this study. 
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The investigator will acknowledge the patient’s valuable contribution in participating in 
the study and explain the long-term goal of assessing the needs of pancreatic cancer 
patients to help clinicians enhance their communication skills and improve the way they 
engage patients in health care decisions.  
7.0 Data Confidentiality: 
 
The questionnaires will not contain identification information but only a participant 
number. Data will only be available to the PI and research team members directly 
involved with the collection and analysis of data related to this project. IRB approval will 
be obtained for any exchange of data outside of MD Anderson. 
 
The members of the research team will be trained to maintain any patient health 
information confidential. Training will be documented as required by institutional policy.  
 
Data Storage:  The questionnaires will not contain identification information but only a 
participant number. The information key linking the participant number to his or her 
identification will be kept separate and secure. The PI and research staff will minimize 
risk by only storing information containing subject identifiers in locked file storage, on 
password-protected computers, and/or in a password protected database. In addition, 
access to patient identifiers will be limited to the minimum number of necessary research 
personnel, and only to those research personnel directly involved with obtaining patient 
information. Keys containing information linking study subjects to personal identifiers 
will be maintained in locked  storage for paper records or behind institutionally approved 
firewall and electronic security measures for electronic keys, and available ONLY to the 
PI and research personnel. Information containing subject personal identifiers will not be 
removed from MD Anderson Cancer Center and will not be shared in publications or 
reports concerning this research study. 
 
Data Sharing:  Study data will not be shared with any individuals or entities that are not 
involved in the study. De-identified data may be shared with IRB-approved collaborating 
sites (PI’s UT-Health Science Center Dissertation Committee). Sharing of data will be 
done only by secured mechanisms, as approved by MD Anderson Information Security.  
 
Final disposition of study records:  These data will be used only for this research study.  
Data that is in hard-copy form will be retained on site until the study is terminated, and 
may be stored indefinitely, per institutional standards, in long-term off-site storage with 
an MD Anderson approved, secured contract site.  Electronic data will be retained 
indefinitely on MD Anderson servers behind the institutional firewall. Data will not be 
shared with any party outside of MD Anderson and will not be retained or disseminated 
for other research without prior IRB approval. 
 
8.0 Distress Plan 
 
Participants will be provided information on the benefits, and the importance of 
knowledge gained from the study.  The voluntary nature of the study will be emphasized 
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and it will be explained to patients and clinicians that declination of participation in the 
study will not affect clinical treatment and/or care.  
The Uncertainty in Illness Theory by Mishel defines uncertainty as a cognitive state 
wherein there is inability to assign value or meaning to illness-related events. Although 
Mishel conceptualized and designed the MUIS-C to measure a cognitive state and 
included no questions that address emotional distress, it is recognized that studes in a 
cancer population could be have associated distress. Since the MUIS-C manual does not 
delineate categories for low/moderate/high levels of uncertainty and because we do not 
know the levels of uncertainty in this population as it has not been previously studied, we 
cannot use the MUIS-C score to judge low-med-high uncertainty and assign a score that 
will prompt implementation of a distress plan. We will observe the patient for signs of 
unease or discomfort with the study and also review the responses so that items with 
answers that state “strongly agree” or for reservely scored items, those with “strongly 
disagree” will be reported to the clinical team so that the patient’s uncertainty over their 
disease and management can be addressed.  
 
The clinical team will also be notified if the patient verbalizes distress so that referral for 
counseling, supportive care, or psychiatry consult can be intiated. The patient will be 
informed that he/she may discontinue participation in the study at any time. 
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1.0 Objectives 
 
1. Describe uncertainty in the pancreatic cancer patient population using the Mishel 
Uncertainty in Illness Scale – Community instrument (MUIS-C) 
 
2. Describe health literacy using the Cancer Health Literacy Test – 30 (CHLT-30) and its 
association to uncertainty in the pancreatic cancer patient population  
 Hypothesis 2a: Higher levels of health literacy are significantly correlated with lower 
levels of uncertainty in pancreatic cancer patients 
 Hypothesis 2b: Health literacy is an independent predictor of uncertainty in pancreatic 
cancer patients after adjusting for age, sex, race, education level, and disease treatment 
stage  
3. Examine if age, sex, race, education level, and disease treatment stage are significant 
predictors of uncertainty and health literacy in the pancreatic cancer population 
 Hypothesis 3a: Education level, race, disease treatment stage are significant predictors 
of uncertainty and of health literacy in pancreatic cancer patients 
 Hypothesis 3b: Age and sex are not significant predictors of uncertainty or of health 
literacy in pancreatic cancer patients 
The primary aim is to determine if a significant correlation exists between of uncertainty 
and health literacy in the pancreatic cancer population (hypothesis 2a). As neither 
uncertainty nor health literacy has been studied in this population, exploratory aims are to 
describe uncertainty and health literacy in pancreatic cancer patients, and to examine for 
significant predictors.  
  
2.0 Rationale 
 
Pancreatic cancer has aggressive biology, vague and distressing symptoms, and lacks 
expert agreement on treatment guidelines for patients with potentially-curable, resectable 
disease. For patients undergoing treatment, there is debate even among experts regarding 
the sequence of therapy for patients with resectable disease (Evans et al., 2008; 
Varadhachary et al., 2008).  The National Comprehensive Cancer Network (NCCI) 
recommends upfront surgery for potentially-resectable pancreatic cancer but expert 
consensus and a number of phase II clinical trials support administration of neoadjuvant 
chemotherapy in selected patients with biopsy-proven carcinoma prior to surgery 
(Halperin & Varadhachary, 2014).  Even for patients who complete treatment, the 
widely-acknowledged high recurrence rate undermines confidence in having achieved 
long-term survival or cure. The 5-year survival rate for pancreatic cancer remains low at 
7% (ACS, 2016) and approximately 80% of patients undergoing resection with curative 
intent develop distant metastasis or local recurrence within five years of surgery 
(Halperin & Varadhachary, 2014).  With a grim prognosis, patients can become overly 
vigilant and mistakenly interpret symptoms unrelated to malignancy as indications of 
disease recurrence. All of these factors contribute to uncertainty, defined as a cognitive 
state wherein there is inability to give meaning to illness events (Mishel, 1988, Mishel & 
Braden, 1988, Mishel, et al., 2009).  ).  It is conceptualized by Mishel within the 
Uncertainty of Illness Theory as a cognitive state that occurs when the decision maker 
unable to assign values to events or is unable to predict outcomes due to cues being 
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lacking or insufficient (Bailey,  et al., 2011).  The framework describes that individuals 
cognitively process illness stimuli then through primary appraisal, derive meaning. 
Uncertainty has been studied in many cancer populations (Bailey et al., 2011; Cahill et 
al., 2014; Elphee, 2008; Germino et al., 2013; McCorkle et al., 2009; Mishel et al., 2002; 
Mishel et al., 2009; Parker et al., 2013) but it has not been studied in pancreatic cancer 
patients.  
 
Uncertainty is linked to poor outcomes (Lin et al., 2015) and one factor that can 
potentially mitigate uncertainty is health literacy, defined as the capacity to obtain, 
process, and understand health information and services needed to make appropriate 
health decisions (Dumenci, 2014). Limited health literacy is also associated with 
unfavorable outcomes in cancer patients (Mahal, 2015; Busch, 2015: Winton, 2016; 
Hawley, 2008; Koay, 2013) and low health literacy is perceived by cancer patients as a 
barrier to good outcomes (Rust, 2011; Rust, 2012). Unfortunately, health literacy has not 
been studied either with a focus on pancreatic cancer patients whose illness experience 
require navigation of complex information and services pathways in order to engage 
successfully in treatment decisions.  
 
Despite the shared link to information processing suggested by their definitions, the 
relationship between uncertainty and health literacy has not been studied in cancer 
patients and has not been studied individually in pancreatic cancer patients. This study 
planned within a framework adapted from Mishel Uncertainty Theory will address these 
gaps (Mishel, 1988, Mishel & Braden, 1988, Mishel, et al., 2009). The model adapted 
from Mishel’s original framework and focused on the antecedent portion of the original 
model is illustrated in Figure 1.  
 
Figure 1. Antecendents of Uncertainty in Pancreatic Cancer Patients 
Adapted from Mishel’s Uncertainty in Illness Theory (Mishel, 1988). 
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In this model, Event Stimuli represents the events during the different phases of diagnosis 
and disease management that the patients may experience. The Structure Providers 
represent factors that can help the patient interpret illness events. Patient Characteristics 
include the patient’s demographics that include age, education level, sex, and race. 
The study will examine demographic and factors to evaluate if there are predictors that 
can guide future research and identification of individuals who are more susceptible to 
uncertainty. Prior health literacy assessment in 1,306 cancer patients found no significant 
mean difference between men and women (p=.247) but the scores among African 
Americans were found to be significantly lower (p < .0001) than White participants 
(Dumenci et al., 2014).  This study found that participants with limited health literacy 
consisted of an overrepresentation of African-Americans, patients who were 
undereducated, and patients with lower income (Dumenci et al., 2014).  Meanwhile 
aggregate data on different population subgroups described in the Uncertainty in Illness 
Scales Manual indicate no difference in the mean scores based on sex or age but that 
scores decrease with an increase in level of education (Mishel, 1997).  These 
demographic variables will be evaluated as this can influence the design and 
implementation of future studies and intended population of intervention programs.  
Moreover, patient uncertainty has been found to vary according to disease treatment stage 
with a brain tumor population study showing variation depending on treatment status 
with newly diagnosed patients and patients on active treatment having high levels of 
uncertainty (Lin et al., 2015). This will be assessed in pancreatic cancer patients to 
facilitate and promote communication between clinicians and patients when making 
health care decisions.  
 
3.0 Eligibility of Subjects 
 
INCLUSION CRITERIA 
1. Patients with a diagnosis of biopsy-proven pancreatic adenocarcinoma who are 
being treated in an Ambulatory Outpatient Clinic at MD Anderson Cancer Center 
Main Campus 
2. Patients with a diagnosis of pancreatic adenocarcinoma who also 
have a history of non-melanoma skin cancer(s) are eligible to 
participate  
3. Patients who meet the above criteria and are 18 years of age or older 
  
EXCLUSION CRITERIA  
1. Patients with pancreatic 
adenocarcinoma who have a history 
or current diagnosis of another 
primary malignancy for which: 
 oncologic treatment is currently being administered or has been 
administered within past the five years  
 there has been evidence of disease within the past five years related to the 
patient’s other malignancy  
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2. Patients unable to speak, read, or write in English will be excluded because the 
study instruments are in English 
3. Pancreatic adenocarcinoma patients who are under 18 years of age 
 
4.0 Research Plan and Methods 
 
The study is designed as an observational, cross-sectional study seeking to describe 
uncertainty in illness and health literacy in the pancreatic cancer population and explore 
the relationship between these variables.  Given the absence of prior studies on 
uncertainty and health literacy in pancreatic cancer patients, this design is appropriate as 
an exploration that can provide groundwork for future research.   Written approval prior 
to the initiation of the study will be obtained from the Institutional review Board of MD 
Anderson. The principal investigator (PI) will provide training to study staff prior to data 
collection. 
 
Recruitment:  
Patients who meet the eligibility criteria will be invited to participate in the study when 
they present for a clinic visit by the investigator and will be approached to obtain 
informed consent.  This study and the recruitment will be conducted in the outpatient 
clinic during a patient’s scheduled visit to the clinic. Patients will not be required to 
report to clinic for the purpose of study participation on days when they otherwise do 
not have a scheduled visit for cancer treatment or follow-up.  
 
Collaboration and coordination with the clinic team seeing the patients will be 
established for the study prior to beginning screening, recruitment, and enrollment. The 
eligibility review and recruitment will be as follows: 
 
1. Primary investigator will pre-screen the patients scheduled to attend 
pancreatic cancer clinic in preparation for the research study  
2. Primary investigator will send the list of eligible patients to the clinic team 
and obtain permission to recruit the patients in clinic on the day of their 
visits  
3. Primary investigator will approach the eligible patients in clinic on a 
consecutive basis to explain the study and invite their participation 
4. The primary investigator will explain the Informed Consent process and 
voluntary nature of study participation and address patient questions 
5. The principal investigator will obtain signatures for Informed Consent 
6. A copy of the completed consent will be kept in the electronic health 
record system  
7. A copy of the completed consent will be offered to the patient and given to 
those who want to keep a copy for their personal records  
 
Registration: 
Enrolled patients will be registered into the Clinical Oncology Research System (CORe) 
which serves as the MD Anderson Cancer Center institutional patient data management 
system. 
120 
 
 
 
 
 
Data Collection:  
The questionnaires will not contain identifiers but will only have a participant number. 
Enrolled patients will complete the instruments in the clinic. Collaboration and 
coordination with the clinic team seeing the patients will be established for the study prior 
to beginning screening, recruitment, and enrollment.  
The participants will complete the questionnaires in the clinic room or waiting area before 
they are seen by the physician during their visit. 
 
1. Data will be collected by paper and pencil surveys with the investigator entering 
information into the web-based REDCap application hosted by MD Anderson 
Cancer Center (https://redcap.mdanderson.org) 
2. The investigator or a clinical research staff will be available in clinic during the 
time the patient is completing the instruments 
3. The investigator or research staff may not provide any answers to the specific 
questions on the questionnaire but can address questions about study participation 
or the process of form completion  
4. Only the patient may complete the form. Family members or patient companions 
to the visit may not answer or complete the forms. If there are deficits that makes 
reading the questionnaire or writing the responses difficult, the questionnaire can 
be read to the patient by the research staff or the patient companion and the 
responses recorded according to the patient response 
5. Investigator or research staff will review the forms to ensure completeness or that 
the participant has responded to all the items that want to answer. The primary 
investigator will keep the completed forms to a secure location in the primary 
investigator’s office  
6. Participants will not take home their questionnaires for completion. If a 
participant does not complete his or her participation while in clinic, the 
participant will not be included in the sample to be analyzed. 
 
Recruitment and informed consents is anticipated to take 20 minutes while the time to 
complete the instruments is anticipated to take approximately 20 minutes with a total 
participation time of 40 minutes.  The primary investigator will enter the data into the 
secure RedCap database. Data entry and instrument scoring will be conducted according 
to the instrument manuals and study protocol prepared for the study.   
 
INSTRUMENTS 
 
The Mishel Uncertainty in Illness Scale – Community Form (MUIS-C) will be used to 
measure uncertainty.  The MUIS-C has 23 items scored 1 to 5 on a Likert scale.  The item 
scores are summed with a higher cumulative score indicating greater uncertainty.  The 
MUIS-C has been used extensively with cancer patients.  The MUIS-C was adapted from 
the 33-item Mishel Uncertainty in Illness Scale (MUIS-A), originally developed to 
evaluate uncertainty in acutely ill, hospitalized adults (Bailey et al., 2011).  Items from 
the MUIS-A specifically relating to inpatient hospitalization were removed and the 
remaining questions comprise the items for the MUIS-C version.  The MUIS-A was 
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developed through expert analysis and validation of the MUIS-A was utilized to support 
the validity of the MUIS-C (Bailey et al., 2011).  In analyses of MUIS-C scores from 18 
samples of chronically ill adults (total n=1068), Cronbach’s alpha exceeded 0.85 in a 
large majority of the samples indicating the reliability of MUIS-C as comparable to the 
0.87 reported for the MUIS-A (Bailey et al., 2011).  Scores can range from 23 to 115 
with a higher score indicating higher uncertainty. There is no categorical delineation 
regarding what is considered as “low”, “moderate” or “high” uncertainty.    
 
The Cancer Health Literacy Test – 30 (CHLT-30) (Dumenci, et. al., 2014) will be used to 
measure health literacy.  The 30-item CHLT-30 was created to assess literacy along the 
cancer health literacy continuum.  Its development was described in a publication of a 
study involving 1,306 adults with heterogenous cancer diagnoses, educational attainment, 
and health insurance and marital status.  Pancreatic cancer was not listed as a category 
among the 11 diagnostic cancer types represented by the participants in the study sample.  
The reliability evidence for the CHLT-30 was a Cronbach’s alpha of 0.88, McDonald’s 
omega of 0.89, 2-week test–retest reliability of 0.90, and 6-month test–retest reliability of 
0.90.  There was support for the unidimensional scale and all variables had significant 
factor loadings of > 0.44.  Structural equation modeling supported external validity with 
self-confidence in engaging in health decisions specified as a latent variable measured by 
two positively and two negatively worded items.  The test score is the total number of 
correct responses and ranges from 0 to 30.  The instrument response time ranges from 10-
15 minutes (Dumenci, et. al., 2014). 
A Patient Demographic Form will be utilized to record demographic information 
including age, sex, education level, race, and disease treatment stage.    
5.0 Statistics and Justification of Sample Size 
 
The sample size calculation is based on the primary aim to determine a correlation 
between uncertainty and health literacy.  An estimated total of up to 91 patients will be 
invited to participate.  With an anticipated response rate of approximately 90%, an 
analyzable sample size of 82 will be produced. The primary objective is to collect the 
uncertainty and health literacy information in pancreatic cancer patients and assess the 
correlation between uncertainty and health literacy. The primary endpoints are the 
Mishel uncertainty scores, which is defined as the summation of all the questions 
scores and the cancer health literacy test scores which is defined as the number of 
questions that the patient answers correctly.  With 82 patients in total, given the two-
sided type I error of 5%, we will have an 80% power to detect a Pearson’s correlation 
of 0.3 between uncertainty score and cancer health literacy score. nQuery/nTerim 
version 3.0 was used for the sample size justification. 
Questionnaire scores will be calculated based on standardized manuals associated with 
each survey instrument.  Descriptive statistics will be used to summarize scores of the 
questionnaires according to respective scoring manuals for each of the measures. The 
distribution of each continuous variable will be summarized by its mean, standard 
deviation, median, and range.  The distribution of each categorical variable will be 
summarized in terms of its frequencies and percentages.  The difference in uncertainty 
and health literacy scores will be assessed between groups (e.g. gender, education 
levels) by a two-sample t-test or ANOVA if the data is normally distributed; otherwise 
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a Wilcoxon rank sum or Kruskal-Wallis test will be used.  The association between 
uncertainty scores and health literacy score will be examined by Pearson correlation. 
To identify factors associated with uncertainty or health literacy scores of the survey 
measures, for example, the patient education level, age, race, and gender, multivariate 
linear regression will be performed to examine their effects.  Specifically, the 
hypotheses testing and anticipated results are as follows:  
 
1. Describe uncertainty in the pancreatic cancer patient population using the MUIS - 
this primary, exploratory aim will assessed using Descriptive Analysis and Analysis 
of Variance (ANOVA)    
 
2. Describe health literacy using the CHLT-30 and its association to uncertainty in the 
pancreatic cancer patient population  
Hypothesis 2a: Higher levels of health literacy are significantly correlated with 
lower levels of uncertainty in pancreatic cancer patients - Pearson product 
moment correlation coefficient will be calculated. Kendall’s tau b or Spearman rho 
will be used if there is not a linear relationship or normal distribution. The 
anticipated result will be an inverse linear association between uncertainty and 
health literacy.  
Hypothesis 2b: Health literacy is an independent significant predictor of 
uncertainty in pancreatic cancer patients after adjusting for age, sex, education 
level, race, disease treatment stage - Health literacy will be included in 
multivariate regression to evaluate if it is a significant predictor of uncertainty after 
adjusting for other variables under study. 
 
3. Examine significant demographic predictors of uncertainty and health literacy in the 
pancreatic cancer population 
Hypothesis 3a: Education level, race, disease treatment stage are significant 
predictors of uncertainty and of health literacy in pancreatic cancer patients – 
Multiple linear regression will be performed to determine if these variables are 
significant predictors for uncertainty and multivariate regression will be also be 
performed to assess if they are significant predictors for health literacy as well. The 
anticipated results will be that education level, race, and disease treatment stage will 
be significant predictors for both health literacy and uncertainty. 
Hypothesis 3b: Age and sex are not significant predictors of uncertainty or of 
health literacy in pancreatic cancer patients - Multivariate regression will be 
performed to determine if age and sex are significant predictors for uncertainty and 
multivariate regression will be also be performed assess if they are significant 
predictors for health literacy as well. The anticipated results will be that neither age 
not sex will come out as significant predictors for either uncertainty or health 
literacy.   
 
6.0 Informed Consent Process   
 
Participants 18 years of age and older will be consented in the clinic during scheduled 
visits. They will be consented by the study PI or by authorized, trained research personnel 
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listed on the Delegation of Authority. This study has minimal risks and does not provide 
treatment. 
 
Patients will be given the opportunity to review study documents and ask questions, and 
will be given time to consider their participation prior to signing the consent. This study 
is limited to English-speaking patients, due to the instruments only being available in 
English, therefore, patients who are unable to read, write, and understand English will not 
be consented to this study. 
 
The investigator will acknowledge the patient’s valuable contribution in participating in 
the study and explain the long-term goal of assessing the needs of pancreatic cancer 
patients to help clinicians enhance their communication skills and improve the way they 
engage patients in health care decisions.  
7.0 Data Confidentiality: 
 
The questionnaires will not contain identification information but only a participant 
number. Data will only be available to the PI and research team members directly 
involved with the collection and analysis of data related to this project. IRB approval will 
be obtained for any exchange of data outside of MD Anderson. 
 
The members of the research team will be trained to maintain any patient health 
information confidential. Training will be documented as required by institutional policy.  
Data Storage:  The questionnaires will not contain identification information but only a 
participant number. The information key linking the participant number to his or her 
identification will be kept separate and secure. The PI and research staff will minimize 
risk by only storing information containing subject identifiers in locked file storage, on 
password-protected computers, and/or in a password protected database. In addition, 
access to patient identifiers will be limited to the minimum number of necessary research 
personnel, and only to those research personnel directly involved with obtaining patient 
information. Keys containing information linking study subjects to personal identifiers 
will be maintained in locked  storage for paper records or behind institutionally approved 
firewall and electronic security measures for electronic keys, and available ONLY to the 
PI and research personnel. Information containing subject personal identifiers will not be 
removed from MD Anderson Cancer Center and will not be shared in publications or 
reports concerning this research study. 
 
Data Sharing:  Study data will not be shared with any individuals or entities that are not 
involved in the study. De-identified data may be shared with IRB-approved collaborating 
sites (PI’s UT-Health Science Center Dissertation Committee). Sharing of data will be 
done only by secured mechanisms, as approved by MD Anderson Information Security.  
Final disposition of study records:  These data will be used only for this research study.  
Data that is in hard-copy form will be retained on site until the study is terminated, and 
may be stored indefinitely, per institutional standards, in long-term off-site storage with 
an MD Anderson approved, secured contract site.  Electronic data will be retained 
indefinitely on MD Anderson servers behind the institutional firewall. Data will not be 
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shared with any party outside of MD Anderson and will not be retained or disseminated 
for other research without prior IRB approval. 
 
8.0 Distress Plan 
 
Participants will be provided information on the benefits, and the importance of 
knowledge gained from the study.  The voluntary nature of the study will be emphasized 
and it will be explained to patients and clinicians that declination of participation in the 
study will not affect clinical treatment and/or care.  
 
The Uncertainty in Illness Theory by Mishel defines uncertainty as a cognitive state 
wherein there is inability to assign value or meaning to illness-related events. Although 
Mishel conceptualized and designed the MUIS-C to measure a cognitive state and 
included no questions that address emotional distress, it is recognized that studes in a 
cancer population could be have associated distress. Since the MUIS-C manual does not 
delineate categories for low/moderate/high levels of uncertainty and because we do not 
know the levels of uncertainty in this population as it has not been previously studied, we 
cannot use the MUIS-C score to judge low-med-high uncertainty and assign a score that 
will prompt implementation of a distress plan. We will observe the patient for signs of 
unease or discomfort with the study and also review the responses so that items with 
answers that state “strongly agree” or for reservely scored items, those with “strongly 
disagree” will be reported to the clinical team so that the patient’s uncertainty over their 
disease and management can be addressed.  
 
The clinical team will also be notified if the patient verbalizes distress so that referral for 
counseling, supportive care, or psychiatry consult can be intiated. The patient will be 
informed that he/she may discontinue participation in the study at any time. 
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1.0 Objectives 
 
1. Describe uncertainty in the pancreatic cancer patient population using the Mishel 
Uncertainty in Illness Scale – Community instrument (MUIS-C) 
2. Describe health literacy using the Cancer Health Literacy Test – 30 (CHLT-30) and its 
association to uncertainty in the pancreatic cancer patient population  
 Hypothesis 2a: Higher levels of health literacy are significantly correlated with lower 
levels of uncertainty in pancreatic cancer patients 
 Hypothesis 2b: Health literacy is an independent predictor of uncertainty in pancreatic 
cancer patients after adjusting for age, sex, race, education level, and disease treatment 
stage  
3. Examine if age, sex, race, education level, and disease treatment stage are significant 
predictors of uncertainty and health literacy in the pancreatic cancer population 
 Hypothesis 3a: Education level, race, disease treatment stage are significant predictors 
of uncertainty and of health literacy in pancreatic cancer patients 
 Hypothesis 3b: Age and sex are not significant predictors of uncertainty or of health 
literacy in pancreatic cancer patients 
 
The primary aim is to determine if a significant correlation exists between of uncertainty 
and health literacy in the pancreatic cancer population (hypothesis 2a). As neither 
uncertainty nor health literacy has been studied in this population, exploratory aims are to 
describe uncertainty and health literacy in pancreatic cancer patients, and to examine for 
significant predictors.   
2.0 Rationale 
 
Pancreatic cancer has aggressive biology, vague and distressing symptoms, and lacks 
expert agreement on treatment guidelines for patients with potentially-curable, resectable 
disease. For patients undergoing treatment, there is debate even among experts regarding 
the sequence of therapy for patients with resectable disease (Evans et al., 2008; 
Varadhachary et al., 2008).  The National Comprehensive Cancer Network (NCCI) 
recommends upfront surgery for potentially-resectable pancreatic cancer but expert 
consensus and a number of phase II clinical trials support administration of neoadjuvant 
chemotherapy in selected patients with biopsy-proven carcinoma prior to surgery 
(Halperin & Varadhachary, 2014).  Even for patients who complete treatment, the 
widely-acknowledged high recurrence rate undermines confidence in having achieved 
long-term survival or cure. The 5-year survival rate for pancreatic cancer remains low at 
7% (ACS, 2016) and approximately 80% of patients undergoing resection with curative 
intent develop distant metastasis or local recurrence within five years of surgery 
(Halperin & Varadhachary, 2014).  With a grim prognosis, patients can become overly 
vigilant and mistakenly interpret symptoms unrelated to malignancy as indications of 
disease recurrence. All of these factors contribute to uncertainty, defined as a cognitive 
state wherein there is inability to give meaning to illness events (Mishel, 1988, Mishel & 
Braden, 1988, Mishel, et al., 2009).  ).  It is conceptualized by Mishel within the 
Uncertainty of Illness Theory as a cognitive state that occurs when the decision maker 
unable to assign values to events or is unable to predict outcomes due to cues being 
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lacking or insufficient (Bailey,  et al., 2011).  The framework describes that individuals 
cognitively process illness stimuli then through primary appraisal, derive meaning. 
Uncertainty has been studied in many cancer populations (Bailey et al., 2011; Cahill et 
al., 2014; Elphee, 2008; Germino et al., 2013; McCorkle et al., 2009; Mishel et al., 2002; 
Mishel et al., 2009; Parker et al., 2013) but it has not been studied in pancreatic cancer 
patients.  
 
Uncertainty is linked to poor outcomes (Lin et al., 2015) and one factor that can 
potentially mitigate uncertainty is health literacy, defined as the capacity to obtain, 
process, and understand health information and services needed to make appropriate 
health decisions (Dumenci, 2014). Limited health literacy is also associated with 
unfavorable outcomes in cancer patients (Mahal, 2015; Busch, 2015: Winton, 2016; 
Hawley, 2008; Koay, 2013) and low health literacy is perceived by cancer patients as a 
barrier to good outcomes (Rust, 2011; Rust, 2012). Unfortunately, health literacy has not 
been studied either with a focus on pancreatic cancer patients whose illness experience 
require navigation of complex information and services pathways in order to engage 
successfully in treatment decisions.  
 
Despite the shared link to information processing suggested by their definitions, the 
relationship between uncertainty and health literacy has not been studied in cancer 
patients and has not been studied individually in pancreatic cancer patients. This study 
planned within a framework adapted from Mishel Uncertainty Theory will address these 
gaps (Mishel, 1988, Mishel & Braden, 1988, Mishel, et al., 2009). The model adapted 
from MIshel’s orginal framework and focused on the antecedent portion of the original 
model is illustrated in Figure 1.  
 
Figure 1. Antecendents of Uncertainty in Pancreatic Cancer Patients 
Adapted from Mishel’s Uncertainty in Illness Theory (Mishel, 1988). 
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In this model, Event Stimuli represents the events during the different phases of diagnosis 
and disease management that the patients may experience. The Structure Providers 
represent factors that can help the patient interpret illness events. Patient Characteristics 
include the patient’s demographics that include age, education level, sex, and race. 
The study will examine demographic and factors to evaluate if there are predictors that 
can guide future research and identification of individuals who are more susceptible to 
uncertainty. Prior health literacy assessment in 1,306 cancer patients found no significant 
mean difference between men and women (p=.247) but the scores among African 
Americans were found to be significantly lower (p < .0001) than White participants 
(Dumenci et al., 2014).  This study found that participants with limited health literacy 
consisted of an overrepresentation of African-Americans, patients who were 
undereducated, and patients with lower income (Dumenci et al., 2014).  Meanwhile 
aggregate data on different population subgroups described in the Uncertainty in Illness 
Scales Manual indicate no difference in the mean scores based on sex or age but that 
scores decrease with an increase in level of education (Mishel, 1997).  These 
demographic variables will be evaluated as this can influence the design and 
implementation of future studies and intended population of intervention programs.  
Moreover, patient uncertainty has been found to vary according to disease treatment stage 
with a brain tumor population study showing variation depending on treatment status 
with newly diagnosed patients and patients on active treatment having high levels of 
uncertainty (Lin et al., 2015). This will be assessed in pancreatic cancer patients to 
facilitate and promote communication between clinicians and patients when making 
health care decisions.  
  
3.0 Eligibility of Subjects 
 
Inclusion Criteria 
1. Patients with a diagnosis of pancreatic adenocarcinoma who are being treated in 
an Ambulatory Outpatient Clinic at MD Anderson Cancer Center Main Campus 
2. Patients with a diagnosis of pancreatic adenocarcinoma who are 18 years old or 
older 
 
Exclusion Criteria 
1. Patients with pancreatic adenocarcinoma who have: 
a. evidence of active disease, metastasis, or recurrence of another primary 
malignancy, except non-melanoma skin cancer, within the past 5 years  
b. a personal history of another primary malignancy, except non-melanoma 
skin cancer, for which oncologic treatment has been administered within 
the past 5 years  
2. Patients unable to speak, read, or write in English  
3. Pancreatic adenocarcinoma patients who are under 18 years of age 
 
4.0 Research Plan and Methods 
 
132 
 
 
 
 
The study is designed as an observational, cross-sectional study seeking to describe 
uncertainty in illness and health literacy in the pancreatic cancer population and explore 
the relationship between these variables.  Given the absence of prior studies on 
uncertainty and health literacy in pancreatic cancer patients, this design is appropriate as 
an exploration that can provide groundwork for future research.   Written approval prior 
to the initiation of the study will be obtained from the Institutional review Board of MD 
Anderson. The principal investigator (PI) will provide training to study staff prior to data 
collection. 
 
Recruitment:  
Patients who meet the eligibility criteria will be invited to participate in the study when 
they present for a clinic visit by the investigator and will be approached to obtain 
informed consent.  This study and the recruitment will be conducted in the outpatient 
clinic during a patient’s scheduled visit to the clinic. Patients will not be required to 
report to clinic for the purpose of study participation on days when they otherwise do 
not have a scheduled visit for cancer treatment or follow-up.  
 
Collaboration and coordination with the clinic team seeing the patients will be 
established for the study prior to beginning screening, recruitment, and enrollment. The 
eligibility review and recruitment will be as follows: 
 
1. Primary investigator will pre-screen the patients scheduled to attend 
pancreatic cancer clinic in preparation for the research study  
2. Primary investigator will send the list of eligible patients to the clinic team 
and obtain permission to recruit the patients in clinic on the day of their 
visits  
3. Primary investigator will approach the eligible patients in clinic on a 
consecutive basis to explain the study and invite their participation 
4. The primary investigator will explain the Informed Consent process and voluntary 
nature of study participation and address patient questions 
5. The principal investigator will obtain signatures for Informed Consent 
6. A copy of the completed consent will be kept in the electronic health 
record system  
7. A copy of the completed consent will be offered to the patient and given to 
those who want to keep a copy for their personal records  
 
 
Registration: 
Enrolled patients will be registered into the Clinical Oncology Research System (CORe) 
which serves as the MD Anderson Cancer Center institutional patient data management 
system. 
 
Data Collection:  
The questionnaires will not contain identifiers but will only have a participant number. 
Enrolled patients will complete the instruments in the clinic. Collaboration and 
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coordination with the clinic team seeing the patients will be established for the study prior 
to beginning screening, recruitment, and enrollment.  
 
The participants will complete the MUIS-C questionnaires measuring uncertainty in the 
clinic room or waiting area before they are seen by the physician during their visit. 
1. Data will be collected by paper and pencil surveys with the investigator entering 
information into the web-based REDCap application hosted by MD Anderson 
Cancer Center (https://redcap.mdanderson.org) 
2. The investigator or a clinical research staff will be available in clinic during the 
time the patient is completing the instruments 
3. The investigator or research staff may not provide any answers to the specific 
questions on the questionnaire but can address questions about study participation 
or the process of form completion  
4. Only the patient may complete the form. Family members or patient companions 
to the visit may not answer or complete the forms. If there are deficits that makes 
reading the questionnaire or writing the responses difficult, the questionnaire can 
be read to the patient by the research staff or the patient companion and the 
responses recorded according to the patient response 
5. Investigator or research staff will review the forms to ensure completeness or that 
the participant has responded to all the items that want to answer. The primary 
investigator will keep the completed forms to a secure location in the primary 
investigator’s office  
6. Participants will not take home their questionnaires for completion. If a 
participant does not complete his or her participation while in clinic, the 
participant will not be included in the sample to be analyzed. 
 
Recruitment and informed consents is anticipated to take 20 minutes while the time to 
complete the instruments is anticipated to take approximately 20 minutes with a total 
participation time of 40 minutes.  The primary investigator will enter the data into the 
secure RedCap database. Data entry and instrument scoring will be conducted according 
to the instrument manuals and study protocol prepared for the study.   
 
INSTRUMENTS 
 
The Mishel Uncertainty in Illness Scale – Community Form (MUIS-C) will be used to 
measure uncertainty.  The MUIS-C has 23 items scored 1 to 5 on a Likert scale.  The item 
scores are summed with a higher cumulative score indicating greater uncertainty.  The 
MUIS-C has been used extensively with cancer patients.  The MUIS-C was adapted from 
the 33-item Mishel Uncertainty in Illness Scale (MUIS-A), originally developed to 
evaluate uncertainty in acutely ill, hospitalized adults (Bailey et al., 2011).  Items from 
the MUIS-A specifically relating to inpatient hospitalization were removed and the 
remaining questions comprise the items for the MUIS-C version.  The MUIS-A was 
developed through expert analysis and validation of the MUIS-A was utilized to support 
the validity of the MUIS-C (Bailey et al., 2011).  In analyses of MUIS-C scores from 18 
samples of chronically ill adults (total n=1068), Cronbach’s alpha exceeded 0.85 in a 
large majority of the samples indicating the reliability of MUIS-C as comparable to the 
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0.87 reported for the MUIS-A (Bailey et al., 2011).  Scores can range from 23 to 115 
with a higher score indicating higher uncertainty. There is no categorical delineation 
regarding what is considered as “low”, “moderate” or “high” uncertainty.    
 
The Cancer Health Literacy Test – 30 (CHLT-30) (Dumenci, et. al., 2014) will be used to 
measure health literacy.  The 30-item CHLT-30 was created to assess literacy along the 
cancer health literacy continuum.  Its development was described in a publication of a 
study involving 1,306 adults with heterogenous cancer diagnoses, educational attainment, 
and health insurance and marital status.  Pancreatic cancer was not listed as a category 
among the 11 diagnostic cancer types represented by the participants in the study sample.  
The reliability evidence for the CHLT-30 was a Cronbach’s alpha of 0.88, McDonald’s 
omega of 0.89, 2-week test–retest reliability of 0.90, and 6-month test–retest reliability of 
0.90.  There was support for the unidimensional scale and all variables had significant 
factor loadings of > 0.44.  Structural equation modeling supported external validity with 
self-confidence in engaging in health decisions specified as a latent variable measured by 
two positively and two negatively worded items.  The test score is the total number of 
correct responses and ranges from 0 to 30.  The instrument response time ranges from 10-
15 minutes (Dumenci, et. al., 2014). A Patient Demographic Form will be utilized to 
record demographic information including age, sex, education level, race, and disease 
treatment stage.    
 
5.0 Statistics and Justification of Sample Size 
 
The sample size calculation is based on the primary aim to determine a correlation 
between uncertainty and health literacy. An estimated total of up to 91 patients will be 
invited to participate.  With an anticipated response rate of approximately 90%, an 
analyzable sample size of 82 will be produced. The primary objective is to collect the 
uncertainty and health literacy information in pancreatic cancer patients and assess the 
correlation between uncertainty and health literacy. The primary endpoints are the 
Mishel uncertainty scores, which is defined as the summation of all the questions 
scores and the cancer health literacy test scores which is defined as the number of 
questions that the patient answers correctly.  With 82 patients in total, given the two-
sided type I error of 5%, we will have an 80% power to detect a Pearson’s correlation 
of 0.3 between uncertainty score and cancer health literacy score. nQuery/nTerim 
version 3.0 was used for the sample size justification. 
 
Questionnaire scores will be calculated based on standardized manuals associated with 
each survey instrument.  Descriptive statistics will be used to summarize scores of the 
questionnaires according to respective scoring manuals for each of the measures. The 
distribution of each continuous variable will be summarized by its mean, standard 
deviation, median, and range.  The distribution of each categorical variable will be 
summarized in terms of its frequencies and percentages.  The difference in uncertainty 
and health literacy scores will be assessed between groups (e.g. gender, education 
levels) by a two-sample t-test or ANOVA if the data is normally distributed; otherwise 
a Wilcoxon rank sum or Kruskal-Wallis test will be used.  The association between 
uncertainty scores and health literacy score will be examined by Pearson correlation. 
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To identify factors associated with uncertainty or health literacy scores of the survey 
measures, for example, the patient education level, age, race, and gender, multivariate 
linear regression will be performed to examine their effects.  
 
 
Specifically, the hypotheses testing and anticipated results are as follows:  
1. Describe uncertainty in the pancreatic cancer patient population using the MUIS - 
this primary, exploratory aim will assessed using Descriptive Analysis and Analysis 
of Variance (ANOVA)    
 
2. Describe health literacy using the CHLT-30 and its association to uncertainty in the 
pancreatic cancer patient population  
Hypothesis 2a: Higher levels of health literacy are significantly correlated with 
lower levels of uncertainty in pancreatic cancer patients - Pearson product 
moment correlation coefficient will be calculated. Kendall’s tau b or Spearman rho 
will be used if there is not a linear relationship or normal distribution. The 
anticipated result will be an inverse linear association between uncertainty and 
health literacy.  
Hypothesis 2b: Health literacy is an independent significant predictor of 
uncertainty in pancreatic cancer patients after adjusting for age, sex, education 
level, race, disease treatment stage - Health literacy will be included in 
multivariate regression to evaluate if it is a significant predictor of uncertainty after 
adjusting for other variables under study. 
 
3. Examine significant demographic predictors of uncertainty and health literacy in the 
pancreatic cancer population 
Hypothesis 3a: Education level, race, disease treatment stage are significant 
predictors of uncertainty and of health literacy in pancreatic cancer patients – 
Multiple linear regression will be performed to determine if these variables are 
significant predictors for uncertainty and multivariate regression will be also be 
performed to assess if they are significant predictors for health literacy as well. The 
anticipated results will be that education level, race, and disease treatment stage will 
be significant predictors for both health literacy and uncertainty. 
Hypothesis 3b: Age and sex are not significant predictors of uncertainty or of 
health literacy in pancreatic cancer patients - Multivariate regression will be 
performed to determine if age and sex are significant predictors for uncertainty and 
multivariate regression will be also be performed assess if they are significant 
predictors for health literacy as well. The anticipated results will be that neither age 
not sex will come out as significant predictors for either uncertainty or health 
literacy.   
 
6.0 Informed Consent Process   
 
Participants 18 years of age and older will be consented in the clinic during scheduled 
visits. They will be consented by the study PI or by authorized, trained research personnel 
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listed on the Delegation of Authority. This study has minimal risks and does not provide 
treatment. 
 
Patients will be given the opportunity to review study documents and ask questions, and 
will be given time to consider their participation prior to signing the consent. This study 
is limited to English-speaking patients, due to the instruments only being available in 
English, therefore, patients who are unable to read, write, and understand English will not 
be consented to this study. 
 
The investigator will acknowledge the patient’s valuable contribution in participating in 
the study and explain the long-term goal of assessing the needs of pancreatic cancer 
patients to help clinicians enhance their communication skills and improve the way they 
engage patients in health care decisions.  
 
7.0 Data Confidentiality: 
 
The questionnaires will not contain identification information but only a participant 
number. Data will only be available to the PI and research team members directly 
involved with the collection and analysis of data related to this project. IRB approval will 
be obtained for any exchange of data outside of MD Anderson. 
 
The members of the research team will be trained to maintain any patient health 
information confidential. Training will be documented as required by institutional policy.  
 
Data Storage:  The questionnaires will not contain identification information but only a 
participant number. The information key linking the participant number to his or her 
identification will be kept separate and secure. The PI and research staff will minimize 
risk by only storing information containing subject identifiers in locked file storage, on 
password-protected computers, and/or in a password protected database. In addition, 
access to patient identifiers will be limited to the minimum number of necessary research 
personnel, and only to those research personnel directly involved with obtaining patient 
information. Keys containing information linking study subjects to personal identifiers 
will be maintained in locked  storage for paper records or behind institutionally approved 
firewall and electronic security measures for electronic keys, and available ONLY to the 
PI and research personnel. Information containing subject personal identifiers will not be 
removed from MD Anderson Cancer Center and will not be shared in publications or 
reports concerning this research study. 
 
Data Sharing:  Study data will not be shared with any individuals or entities that are not 
involved in the study. De-identified data may be shared with IRB-approved collaborating 
sites (PI’s UT-Health Science Center Dissertation Committee). Sharing of data will be 
done only by secured mechanisms, as approved by MD Anderson Information Security.  
 
Final disposition of study records:  These data will be used only for this research study.  
Data that is in hard-copy form will be retained on site until the study is terminated, and 
may be stored indefinitely, per institutional standards, in long-term off-site storage with 
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an MD Anderson approved, secured contract site.  Electronic data will be retained 
indefinitely on MD Anderson servers behind the institutional firewall. Data will not be 
shared with any party outside of MD Anderson and will not be retained or disseminated 
for other research without prior IRB approval. 
 
8.0 Distress Plan 
 
Participants will be provided information on the benefits, and the importance of 
knowledge gained from the study.  The voluntary nature of the study will be emphasized 
and it will be explained to patients and clinicians that declination of participation in the 
study will not affect clinical treatment and/or care.  
The Uncertainty in Illness Theory by Mishel defines uncertainty as a cognitive state 
wherein there is inability to assign value or meaning to illness-related events. Although 
Mishel conceptualized and designed the MUIS-C to measure a cognitive state and 
included no questions that address emotional distress, it is recognized that studes in a 
cancer population could be have associated distress. Since the MUIS-C manual does not 
delineate categories for low/moderate/high levels of uncertainty and because we do not 
know the levels of uncertainty in this population as it has not been previously studied, we 
cannot use the MUIS-C score to judge low-med-high uncertainty and assign a score that 
will prompt implementation of a distress plan. We will observe the patient for signs of 
unease or discomfort with the study and also review the responses so that items with 
answers that state “strongly agree” or for reservely scored items, those with “strongly 
disagree” will be reported to the clinical team so that the patient’s uncertainty over their 
disease and management can be addressed.  
 
The clinical team will also be notified if the patient verbalizes distress so that referral for 
counseling, supportive care, or psychiatry consult can be intiated. The patient will be 
informed that he/she may discontinue participation in the study at any time. 
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26. Thyroid Nodules and Thyroid Cancer: An Update 
Philippine Nurses Association Seminar (September 2004) Houston, TX 
 
27. Hypercalcemia and Hyperparathyroidism 
AANP 19th National Conference for Nurse Practitioners (July 2004) New Orleans, 
LA   
 
28. Surgical Treatment of Pancreas Cancer 
Gastrointestinal Center (July 2003) M.D. Anderson Cancer Center, Houston, TX  
 
29. Nursing Care for the Patient Undergoing a Pancreaticoduodenectomy 
Gastrointestinal Center (November 2001) M.D. Anderson Cancer Center, 
 Houston, TX 
 
30. Methadone for Cancer Pain 
Symptom Control and Palliative Care Grand Rounds (March 2001) 
 M.D. Anderson Cancer Center, Houston, TX  
 
31. Use of Methadone in Cancer Pain  
Oncology Update: Advances and Controversies (Feb 2001) Steamboat Springs, 
CO  
 
 
 
PROFESSIONAL MEMBERSHIPS: 
 Texas Nurse Practitioners      2012 - present  
 Oncology Nursing Society      2000 – present 
 Sigma Theta Tau, International Honor Society for Nursing  1992 – present 
 American Association of Nurse Practitioners   2006 - present 
 
 
   
COMMUNITY SERVICE 
 Marit Peterson Foundation Melanoma Research Fund Annual Event 
 Surgical Oncology Advanced Practice Providers Community Outreach Programs 
Annual Melanoma AIM Walk, MD Anderson Cancer Center 
 
 
